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ABSTRACT 
 
 
 
Ehrlichia chaffeensis is an emerging tick-borne rickettsial pathogen that causes infection 
in people and several vertebrate animals.  One of the striking features of E. chaffeensis 
infection is the prolonged persistence in its vertebrate and tick hosts. The mechanism of 
persistent infection and the reasons for the host immune system failure to clear the 
infection are not well understood. One hypothesis is that differential gene expression 
serves as an important adaptive mechanism used by E. chaffeensis in support of its 
continued survival in both tick and vertebrate hosts. One way to test this hypothesis is by 
performing mutational analysis.  However, the methods for introducing mutations in this 
pathogen have not yet been documented and are challenging, possibly due to its obligate, 
intraphagosomal growth requirement. Recently, a novel gene mutation method called 
‘TargeTron Gene Knockout System’ that is based on the modified group II intron 
insertion strategy has been developed. This method appears to be effective in creating 
mutations in a wide range of gram positive and gram negative bacterial organisms. The 
group II intron can be programmed for insertion into virtually any desired DNA target 
with possibly high frequency and specificity. In this study, I focus on creating mutations 
in E. chaffeensis using the TargeTron gene knockout system. I prepared modified group II 
intron constructs retargeting for insertion into three E. chaffeensis genes: Ech_0126 (a 
transcriptionally silent gene), macrophage-specific expressed gene (p28-Omp 19, 
Ech_1143) and tick cell-specific expressed gene (p28-Omp 14, Ech_1136).  In support of 
driving the expression of the modified group II introns in E. chaffeensis, the pathogen-
specific high-expressing gene promoter (tuf) was inserted upstream to the transcription 
start site. In addition, a chloramphenicol acetyltransferase gene with E. chaffeensis rpsl 
promoter was introduced for use as a selection marker.  The constructs were then 
evaluated by transforming into E. chaffeensis. Transformants with mutations, introduced 
in two of the three genes (Ech_0126 and Ech_1143), were identified by PCR and 
Southern blot methods. Although the mutants are detectable for up to 48 hours, 
establishment of stable transformants remains to be challenging. The outcomes of this 
project will have important implications in defining the pathogenesis of E. chaffeensis, 
particularly to assess the differences in the organism in tick and vertebrate hosts. 
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Vector-Borne Diseases 
Vector-borne diseases are the result of pathogen transferring from a vector to a vertebrate 
host, which caused by arthropod vectors including both insect (especially mosquitoes) 
and arachnid (ticks and mites). Mosquito-borne diseases include human malaria, 
filariasis, yellow fever, dengue fever and arthropod-borne viral encephalitis; tick-borne 
diseases include Rocky Mountain spotted fever, tularemia, Colorado tick fever, Q fever 
and relapsing fever; and mite-borne diseases include scrub typhus and scabies. In 
addition, crustacean, including copepods, crabs and prawns, also could transmit 
pathogens and cause diseases. For example, vibrio cholerae can persist in crabs for 
several weeks and multiply itself rapidly in free-living or refrigerated animals (Nalin et 
al., 1979). Vibrio cholerae can also colonize on the surface of copepods, and through 
them, it infects fish and human (Colwell et al, 1992; Estrada et al, 1996). Trematodes 
also harbor pathogens to serve as invertebrate hosts. For example, flukes host 
Neorickettsia species (Fukuda et al., 1981). In addition, Snails also serve as vector for 
transmitting disease agents. For example, they serve as intermediate hosts for 
Schistosomes and Angiostrongglus Cantonensis and cause eosinophilic meningitis in 
human (Lv S et al., 2009). 
 
Classification of the vector-borne diseases includes mechanical and biological vectors. 
Mechanical vectors are the vectors that simply carry pathogen from one host to another. 
For example, houseflies acquire bacteria on their appendages when they land on cow 
dung, and transfer the bacteria to humans when such flies land on food consumed by 
people. In this type of transmission, pathogen does not enter into the body of a 
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mechanical vector. Contrary to mechanical vectors, biological vectors usually harbor 
pathogens inside of their body and transmit to new hosts in a very active way, usually 
through biting. Pathogens develop and multiply themselves inside the body of biological 
vectors before becoming infective. Biological vectors play critical role in the life cycle of 
a pathogen. Many blood-feeding arthropods, such as mosquitoes, ticks, fleas and lice, are 
biological vectors. Some important biological vectors and vector-borne diseases are listed 
in Table 1.1. 
 
Table 1.1 Biologic vectors and vector-borne diseases 
 
Vector                      Scientific name/ group            Disease               Disease pathogen 
Insects 
Body louse               
 
 
Cone nose bugs  
Reduviid bugs    
Assassin bugs     
 
Tsetse flies 
 
 
 
Horse flies 
Sandflies 
 
 
 
Black flies 
Biting midges 
 
 
 
Pediculus humanus   
corporis 
 
Triatoma spp          
Rhodnius spp          
Panstrongylus spp  
 
Glossina spp 
 
 
 
Chrysops spp 
Phlebotomus spp 
 
Lutzomyia spp 
 
Simulium spp 
Culicoides spp 
 
 
 
Epidemic typhus 
Epidemic relapsing fever 
 
 
Chagas’ Disease  
 
 
African Sleeping Sickness 
 
 
 
Loiasis 
Leishmaniasis 
Sandfly Fever 
Oroya Fever 
 
River blindness 
Filariasis 
 
Oropouche Fever 
 
Rickettsia prowazekii 
Borrelia recurrentis 
 
 
Trypanosoma cruzi 
 
 
Trypanosoma brucei 
rhodesiense 
T. b. gambiense 
 
Loa loa 
Leishmania spp 
Arbovirus 
Bartonella 
bacilliformis 
Onchocerca volvμl us 
Mansonella perstans 
M. ozzardi 
Arbovirus 
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Mosquitoes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fleas 
 
 
Mites 
 
Rat mite 
 
 
 
Ticks 
 
Tampan 
Anopheles spp 
 
 
Culex spp 
 
 
 
 
 
 
Aedes spp 
 
 
 
 
 
 
 
Psorophora spp 
 
Haemagogus spp 
Mansonia spp 
 
Coquillettidia spp 
Ochlerotatus spp 
Xenopsylla spp 
 
 
 
 
Leptotrombidium sp 
 
 
 
 
 
Ornithodoros spp 
Malaria 
Lymphatic filariasis 
Onyog’nyong 
Filariasis 
Oropouche           
Ross River           
VEE.                    
WEE                    
St Louis enceph   
Jap. B. enceph    
Yellow fever            
Dengue                     
Rift Valley Fever     
Ross River                
Chikungunya            
EEE                          
Lymphaic filariasis  
                                 
VEE.               
Mayaro               
Yellow Fever    
Lymphatic filariasis 
                                 
EEE 
Ross River 
Bubonic plague 
Murine typhus 
 
 
 
Scrub typhus 
 
 
 
 
 
Endemic Relapsing fever 
Plasmodium spp 
Wuchereria bancrofti 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Arbovirus 
Brugia spp 
Wuchereria bancrofti 
Wuchereria bancrofti 
Wuchereria bancrofti 
Wuchereria bancrofti 
Brugia spp 
Wuchereria bancrofti 
Arbovirus 
Arbovirus 
Yersisia pestis 
Rickettsia typhi 
 
 
 
Rickettsia tsutsugamushi
 
 
 
 
 
Borrelia duttonii 
- 4 - 
Hard tick 
 
Snake tick 
 
Lone star tick 
 
Brown tick 
Bont tick 
 
Bont leg tick 
 
Dog tick 
 
Ixodes spp 
 
Aponomma sp 
 
Dermacentor spp 
 
Rhipicephalus spp 
Hyalomma spp 
 
Amblyomma spp 
 
Haemaphysalis spp 
Spotted Fevers 
Lyme Disease 
Flinders Island Spotted 
Fever 
Rocky Mountain Spotted. 
Fever 
Spotted Fevers 
Congo-Crimean 
Haemorrhagic Fever 
Spotted Fevers 
Ehrlichiosis 
Spotted Fevers 
Rickettsia spp 
Borrelia burgdorferi 
Rickettsia honei 
 
Rickettsia rickettsiae 
 
Rickettsia spp 
 
Arbovirus 
 
Ehrlichia chaffeensis 
Rickettsia spp 
Reference: John M. Goldsmid, Arthropod-borne infections in the tropics: A synopsis 
( www.tropmed.org/primer/chapter13.pdf ) 
 
Despite the improvement of public health infrastructure in recent years, vector-borne 
diseases remain a very important issue for human and animal health. It is reported that 
more than half of total morbidity and mortality in people during the last four centuries 
resulted from vector-borne diseases (Gubler et al., 1998).  The cost associated with 
vector-borne diseases is very huge because of lacking effective prevention and control. 
For example, malaria, a serious and potentially fatal disease caused by female mosquitoes 
of the genus Anopheles, causes 300-500 million clinical episodes and 1.2 million deaths 
each year (WHO, 2009). At the end of 2004, an estimated 3.2 billion people in 107 
countries and territories (about 50% of the world population) live in areas at risk of 
malaria transmission (WHO, 2005). The majority cases of malaria occur in the world’s 
poorest countries, such as sub-Saharan African countries (Harrus et al., 2005). According 
to the World Health Report 2005, it also serves as one of the leading causes of death of 
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children in the developing countries (ranked 5th), and young children under the age of 
five or pregnant women are the most vulnerable group for this disease.  
 
The economic impact of vector-borne diseases, which influence human health, is huge as 
well. For example, the economic impact of malaria in the developing countries accounts 
for 2-3% citizen income (Chima et al., 2003; Russel, 2004).  The direct costs combined 
with other indirect costs cause greater impact. For example, the direct mean cost of 
malaria and other diseases in Nigeria amount to 7% of the household monthly income 
(Onwujekwe et al., 2000). However, if combined with indirect costs, they are responsible 
for more than 75% of the household income (Russel, 2004).  Lyme disease is another 
example. Although it is not fatal, the mean annual incidence for this tick-borne disease in 
the USA during 1993–1996 is 4.73 cases per 100,000 populations. The expected national 
expenditure over 5 years for therapeutic interventions is about 2.5 billion dollars (Maes et 
al., 1998). Chagas disease (American trypanomiasis) is a gradually decreased disease in 
South and Central America. In Brazil, an estimated 516 million dollars are invested in the 
Chagas disease (kissing bug transmitted) control program between 1975 and 1995, of 
which 78% were spent on vector control. The control program is reported to be cost-
effective with each one dollar spent on vector control resulting in 2.01 dollars of savings 
(Hoetz et al., 2004).  
 
Vector-borne diseases also have enormous economic impact on agricultural animals. In 
the 1980s, it is estimated that hemoparasitic diseases of cattle could cost an annual global 
economic loss of 7 billion dollars (Brown, 1997). In the early 1990s, tick borne bovine 
babesiosis and anaplasmosis costed an annual economic loss of 875 -1365 million dollars 
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only in Latin America (James, 1992; Brown, 1997). In Africa, the vector borne diseases 
are also very severe. For example, tick transmitted heartwater disease is estimated to cost 
an economic loss of 5.6 million dollars each year in Zimbabwe (Mukhebi et al., 1999).  
 
Introduction of tick and tick-borne diseases 
Biology of Ticks 
Tick is a common name of small arachnids that belong to the subphylum Chelicerata, 
class Arachnida and order lxodidea (Sonenshine, 1991). It is an obligate blood sucking 
arthropods which have nearly 850 tick species (Oliver, 1989; Sonenshine, 1991). 
According to morphological differences, ticks could be classified as three families: 
Ixodidae, Argasidae and Nuttalliellidae. Ticks from family Ixodidae usually with tough 
sclerotized plate on their dorsal body surface, and thus they are called hard tick. Family 
Aragasidae includes five genera and approximately 170 species were identified. Usually, 
they have a leathery cuticle on the dorsal body surface, and thus they are called soft ticks. 
Family Nuttalliellidae is confined to southern parts of Africa from Tanzania to Namibia 
and South Africa. This family includes only one species- Nuttalliella namaqua (Keirans 
et al., 1976), which is a morphologically intermediate between the families Argasidae 
and Ixodidae.  In general, ticks belonging to family Ixodidae and family Argasidae serve 
as vectors for transmitting infectious agents to animals and people.  
 
The mouthparts of ticks include three visible components (Figure 1.1): two outside 
jointed parts are highly mobile palps and between them are paired chelicerae. The 
chelicerae serve as protector for the center rod-shaped structure named hypostome. It is 
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the hypostome that has beak-like projection which could enter the skin of the host. Some 
backward directed projection prevents easy removal of attached tick from the host. In 
addition, they also secret a cement-like substance from salivary glands and this substance 
glues the body of the tick with the host. When feeding completed, this substance will 
dissolve automatically. The difference between family Ixodidae (hard ticks) and family 
Aragasidae (soft ticks) is that the mouthparts of hard ticks are visible from above, but the 
mouthparts of soft ticks are not readily visible if looked from the same position. 
  
                                            
 
 
 
 
 
 
Figure 1.1  Generalized mouthparts of ticks. 
(Source: http://extension.entm.purdue.edu/publichealth/images/tick/tick02.gif ) 
 
The most important difference between hard ticks and soft ticks lies on their feeding 
styles and life cycles. Hard ticks usually are slow-feeders. They stay in the body of host 
for a few days, and take a large volume of blood meal each time, usually about 200-300 
times of their unfed body weight. For soft ticks, they usually stay in the body of host for a 
few minutes or at most a few hours, and take a small volume of blood meal with only 5-
10 times of their unfed body weight. Compared to hard ticks, soft ticks are fast feeder.  
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 The life cycle of ticks includes four stages: egg, larva, nymph and adult. Eggs hatch into 
six legged larva stage, and then larva molt into nymphal stage after taking a blood meals. 
Hard ticks and soft ticks are very different at this stage. Hard ticks only have one 
nymphal stage. After nymphal stage, they take another blood meal and develop into the 
adult stage. After feeding one more time, female hard ticks lay a batch of thousands of 
eggs and then die. For soft ticks, they molt into a multiple nymphal stages and feed 
several times during each life stage. Unlike hard ticks, female soft ticks lay multiple 
small batches of eggs between blood meals and thus the time of completing their whole 
life cycle is much longer than that of hard ticks, sometimes lasting for more than several 
years. Also, soft ticks require multiple hosts for developing into their adult stages (Figure 
1.3), but hard ticks have less than three hosts all their life (Figure 1.2).  
 
          
 
 
Figure 1.2     One host, two hosts and three hosts of hard ticks. 
(Source: http://entomology.ucdavis.edu/faculty/rbkimsey/tickbio.html) 
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Figure 1.3   Multiple hosts of soft ticks 
(Source: http://www.dpd.cdc.gov/DPDx/HTML/Frames/S-Z/Ticks/body_Ticks_argasid_cycle.htm ) 
 
 
Ticks as vectors 
Ticks are known as vectors for transmitting a diverse group of infectious agents such as 
protozoa, bacteria and virus to vertebrate animals.  For example, protozoan parasite 
Babesia microti transmitted by Ixodes dammini ticks caused infection of human 
babesiosis in the USA (Rodgers et al., 2007).  Borrelia burgdorferi transmitted by 
Amblyomma americium ticks caused Lyme diseases to people (CDC, 2001).  Francisella 
tularensis transmitted by Dermacenter and Haemophysalis species ticks caused infection 
of tularemia in people (Gordon et al., 1983).  Rickettsia rickettsia transmitted by 
Dermacenter species ticks and cause Rocky Mountain spotted fever in the USA (Weber et 
al., 1991).  In addition, Ehrlichia (E. chaffeensis and E. ewingii) and Anaplasma 
phagocytophilum transmitted by Amblyomma and Ixodes ticks caused Ehrlichiosis in 
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people (Dumler et al.,1998; Alciati et al., 2001; Anderson et al., 1993; Bakken et al., 
2000; Buller et al., 1999; Dumler et al., 1998). Tick-born encephalitis virus (TBEV) 
transmitted by Ixodes ticks caused encephalitis and hemorrhagic fever in people in many 
parts of the world (Mitzel et al., 2007). 
 
Tick-borne Rickettsiales Diseases 
Rickettsiales, transmitted by tick, lice, mites, fleas and flukes, include a group of obligate 
intracellular bacteria and most pathogen organisms causing fatal and chronic infections in 
people and vertebrate animals. Tick-borne Rickettsiales diseases are important human 
and animal diseases.  According to the analysis of 16S rRNA, GroESL and several other 
surface protein gene sequences, they can be divided into two families: Rickettsiaceae and 
Anaplasmataceae (Dumler et al., 2001; Fournier et al., 2003).  
 
The family Rickettsiaceae includes two genera: Rickettsia and Orientia. The genus 
Rickettsia has twenty-five species, whereas the genus Orientia has only one species- O. 
tsutsugamushi (Dumler et al., 2001).  The genus Rickettsia can also be subdivided into 
two groups based on the genotypic and phenotypic similarities: the spotted fever group 
rickettsiae (SFGR) and typhus group rickettsiae (TGR) (Raoult et al., 1997; Dumler et al., 
2001). SFGR is mainly transmitted by ticks and TGR is transmitted by flea and lice 
(Walker, 1989; Parola et al., 2001; Raoult et al., 1997; Uchiyama, 2005). Some important 
diseases of SFGR include Rocky Mountain spotted fever (Western 
hemisphere), Rickettsialpox (USA and former Soviet Union), Boutonneuse fever 
(Mediterranean countries, Africa, Southwest Asia and India), Siberian tick typhus (Siberia, 
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Mongolia, northern China), Australian tick typhus (Australia), Oriental spotted fever 
(Japan) and African tick-bite fever (South Africa). Some important diseases of TGR 
include Epidemic, recrudescent and sporadic typhus (worldwide), and Murine (endemic) 
typhus (worldwide). The species O. tsutsugamushi of the genus Orientia is mainly 
transmitted by mites (Rosenberg, 1997; Watt et al., 2003).  A disease named scrub typhus 
formerly known as R. tsutsugamushi has also been reclassified into the genus. 
 
The family Anaplasmataceae includes four genera: Anaplasma, Ehrlichia, Neorickettsia 
and Wolbachia. The genera Anaplasma and Ehrlichia are mainly transmitted by Ixodid 
ticks; the genus Neorickettsia is mainly transmitted by flukes (Dumler et al., 2001; 
Rikihisa, 2003; Hechemy et al., 2003; Raoult et al., 1997; Watt et al., 2003); and the 
genus Wolbachia is endosymbionts in arthropods and nematodes (Bandi et al., 1998; 
Dumler et al., 2001; Jeyaprakash et al., 2000; Werren et al., 2000). Some important tick-
borne diseases of the genus Anaplasma and Ehrlichia in people include: human 
granulocytic anaplasmosis, ewingii ehrlichiosis, and monocytic ehrlichiosis, which are 
caused by Anaplasma phagocytophilum, Ehrlichia ewingii, and Ehrlichia chaffeensis, 
respectively.  The genus Neorickettsia has three species reported pathogenic: 
helminthoeca, risticii and sennetsu (Madigan et al., 2000; Rikihisa et al., 1991; Brown et 
al., 1972). The genus Wolbachia is non-pathogenic symbiotic bacteria resided in insects, 
spiders, mites, ticks and filarial nematodes (Stouthamer et al., 1999). Some of 
Rickettsiale diseases are listed in Table 1.2 and some of well-known tick-borne 
Rickettsiales are discussed below. 
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Table 1.2   Some of Rickettsialea Diseases 
 
Rickettsia species                   Disease                 Vectors                Hosts               Geographic distribution     
 
Typhus group:  
 
Rickettsia prowazekii     Epidemic typhus          Human body         lice Humans              Worldwide    
                                       Recrudescent typhus     None                       Humans                   Worldwide 
                                                                             Lice, fleas            Flying squirrels           Eastern USA  
 
R. typhi                           Murine typhus              Fleas                    Rodents                       Worldwide  
                                                                             Fleas                    Opossums                    USA 
 
R. felis                            Murine typhus like        Fleas                    Opossums                    USA  
 
 
Spotted Fever group:  
 
R. rickettsii                      Rocky Mountain          Ticks            Small mammals,         North & South America 
                                          spotted fever                                 dogs, rabbits, birds 
  
R. conorii                       Boutonneuse fever          Ticks              Rodents, dogs             Africa, Southern        
                                                                                                                                           Europe, India 
 
R. sibirica                      North Asia tick typhus    Ticks                 Rodents                    Eurasia, Asia 
 
R. japonica                     Japanese spotted fever       Ticks           Rodents, dogs                Japan  
 
R. australis                     Queensland tick typhus     Ticks              Rodents                      Australia 
 
R. akari                           Rickettsialpox                   Mites              House mice, rats         Worldwide  
 
 
Ehrlichioses group:  
 
Ehrlichia chaffeensis     Human monocytic             Ticks        Humans, deer              USA, Europe  
                                  ehrlichiosis 
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Anaplasma                    Human granulocytic          Ticks          Humans, deer          USA, Europe 
 phagocytophilum           anaplsamosis                                          rodents 
                                                                              
Ehrlichia ewingii         Human ewingii                   Ticks           Humans, deer          USA, Europe 
                                ehrlichiosis 
Neorickettsia                   Sennetsu ehrlichiosis          Trematode      Humans               Japan, Malaysia 
sennetsu 
 
 
Others:  
 
Orientia tsutsugamushi    Scrub typhus             Mites               Rodents           Asia, Indian  
                                                                                                                                subcontinent, Australia
 
aNot listed are R. helvetica, R. honei, and R. slovaca.  
( source: http://www.cdc.gov/ncidod/eid/vol4no2/azad.htm#Table%201 ) 
 
Rocky Mountain spotted fever 
Rocky Mountain spotted fever (RMSF) is the most severe tick-borne rickettsiale disease 
in the USA, which caused by Rickettsia rickettsii. This rickettsiale organism is primarily 
transmitted by American dog tick (Dermacentor variabilis) and Rocky Mountain wood 
tick (Dermacentor andersoni). In southern region of the United States, the main vectors 
are Rhipicephalus sanguineus (brown dog tick) and Amblyomma cajennense (CDC, 
2010). Humans of all ages are susceptible to RMSF. The pathogen, which spread by 
blood and the lymphatic system, infects the whole body and causes severe damage to 
endothelial cells lining the blood vessels of vital organs (Masters et al., 2003). Although 
this disease is first discovered and named after Rocky Mountain area, recently few cases 
are reported from that area. About half of the cases occur in the south-Atlantic region of 
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the United States: Delaware, Maryland, Washington D.C., Virginia, West Virginia, North 
Carolina, South Carolina, Georgia, and Florida. The highest incidence rates have been 
found in North Carolina and Oklahoma of the USA (CDC, 2010). 
The early clinical signs of RMSF are often nonspecific which may include fever, nausea, 
vomiting, severe headache, muscle pain, lack of appetite. Usually, the characteristic red, 
spotted (petechial) rash is not visible until the sixth day or later after the onset of 
symptoms. Severe cases may also involve infection to the respiratory system, central 
nervous system, gastrointestinal system, or renal system. The mortality of this disease 
ranges from 5% to 10% (Chapman et al., 2006), and most of the mortalities are 
associated with delay in diagnosis (Masters et al., 2003).   
 
Mediterranean spotted fever 
Mediterranean spotted fever (MSF), also known as boutonneuse fever, is a tick-borne 
rickettsiale disease caused by Rickettsia conorii and transmitted by the dog tick 
Rhipicephalus sanguineus (Azad et al., 1998). MSF is reported in the Mediterranean 
countries including southern Europe, northern Africa, and part of Asia (Rovery et al., 
2008).  Because of increased travel to endemic areas, this disease has also been 
transmitted to other regions of the world including central Europe and southern and 
central Africa (Rovery et al., 2008).  After infection, the pathogen invades vascular 
endothelial cells, causing endothelial cells injury and tissue necrosis. Like the other 
rickettsiale diseases, the symptom is non-specific: fever, severe headache, and 
maculopapular rash (Sousa et al., 2003; Rovery et al., 2008). If recognized at the initial 
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stages, MSF can be treated effectively with antibiotics such as chloramphenicol, 
tetracycline or doxycyline (Rovery et al., 2008). 
 
Japanese spotted fever 
Japanese spotted fever, also known as Oriental spotted fever, is another rickettsiale 
disease which transmitted by tick family Ixodidae and caused by Rickettsia japonica. 
This disease was first reported in 1984 in Japan and only confined to the region of 
southwestern Japan, but currently it also has been reported existing in Korea (Ma et al., 
2005). Main symptom of the disease includes fever, headache and the appearance of an 
eschar and rash, and severe cases might involve the damage to the central nervous system 
(Araki et al., 2002).    
 
North Asian tick typhus 
North Asian tick typhus, also called Siberian Tick Typhus, is another tick-borne 
rickettsiale disease which caused by the bacteria Rickettsia sibirica. Symptoms include a 
generalized maculopapular rash involving palms and soles, fever, and lymph node 
enlargement. It occurs in the north, central and east parts of Asia, and because of 
traveling to endemic area, it was also reported in North America (Lewin et al., 2003). 
This disease is rarely fatal and easily cured by treating with chloramphenicol. 
 
Flinders Island spotted fever 
Flinders Island spotted fever was caused by Rickettsia honei and transmitted by Ixodes 
holocylus tick (Stewart, 1991). It was first reported from Flinders Island near Australia in 
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1991 and isolated later in 1998 (Stewart, 1991; Stenos et al., 1998). The pathogen 
proliferates within the endothelial cells of small blood vessels and causes vasculitis. The 
usual symptom of the diseases includes high fever, headache, muscle aches (myalgia), 
slight cough, and arthralgia without joint swelling. Maculopapular rash might occur 5 or 
6 days after tick biting. The disease is rarely fatal and can be cured by treatment of 
tetracyclines.  
 
Australian Spotted Fever 
Australian Spotted Fever, also known as Queensland Tick Typhus, is caused by Rickettsia 
australis and transmitted by Ixodes holocyclus tick (Graves et al., 1993). Like Flinders 
Island spotted fever, the infectious agent proliferates within the endothelial cells of small 
blood vessels and induces vasculitis.  This disease was first reported in 1946 in north 
Queensland (Stewart et al., 1991). The symptom involves fever, headache and muscle 
aches (myalgia). Severe cases might also involve stiff neck, nausea, vomiting and mental 
confusion (Unsworth et al., 2007). This disease is also rarely fatal and more quickly 
cured with treatment of antibiotics (CDC, 2007).  
 
Ehrlichia ewingii 
Ehrlichia ewingii, originally known as the pathogen causing granulocytic ehrlichiosis in 
canines, was recognized in 1999 as the infectious agent for granulocytic ewingii 
ehrilichiosis in humans (Buller et al., 1999). The main natural vector of E. ewingii- the 
lone star tick- Amblyomma americanum and its recent infection in humans have been 
reported from Missouri, Oklahoma, and Tennessee (Buller et al., 1999; Paddock et al., 
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2001). The symptom of the infection includes fever, headache and myalgia, and usually 
reported in cases that recently be exposed to ticks. The diagnosis of this disease is mainly 
through isolation of the agent from tissue culture (Childs et al., 1999), and identification 
by PCR assay with two regions of gene sets serving as primers-16S rRNA genes and 
groE genes (Breitschwerdt et al., 1998; Buller et al., 1999; Sumner et al., 2000). The 
disease can be effectively cured with antibiotics like doxycyline.   
 
Human Granulocytic Anaplasmosis 
Human granulocytic anaplasmosis (HGA), previously known as human granulocytic 
ehrlichiosis, is caused by a bacteria called Anaplasma phagocytophilum and mainly 
transmitted by deer tick- Ixodes scapularis. This disease was first identified in 1990 in a 
Wisconsin patient who died from a febrile disease after two weeks of tick bite (Chen et 
al., 1994). Although it is mostly reported from Northeastern and upper Midwestern 
regions of the United States where the Ixodes ticks are highly prevalent (Demma et al., 
2006), it also appeared in Pacific western states of the USA (Richter, 1996; Barlough, 
1997) and western Europe (Stedink, 1997), where Ixodes pacificus (the black-legged tick) 
and Ixodes ricinus (the sheep tick) are prolific. The pathogen targets at white blood cells 
called neutrophils. Symptom of this disease includes high fever, severe headache, malaise, 
anorexia, nausea, cough and nonspecific rash. The duration time may only last a couple 
of days, but may also persist longer if untreated. This disease is also rarely fatal and can 
be treated effectively with antibiotics such as doxycyline.     
 
Human Monocytic Ehrlichiosis 
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Human monocytic ehrlichiosis (HME), caused by Ehrilchia chaffeensis and transmitted 
by the lone star tick Amblyomma americanum, is one of the most important tick-borne 
Rickettsiale diseases in the USA.  The pathogen is maintained in nature mainly in dual 
hosts, white-tailed deer (Odocoileus virginianus) and the lone star tick Amblyomma 
americanum (Dawson et al., 1994; Lockhart et al., 1995). HME cases were reported from 
the south-central, southeastern, and mid-Atlantic states of the USA, which corresponds to 
the geographical distribution of the lone star tick (CDC, 2009). Some cases may also be 
reported from the outside of the expected regions of the lone star tick, because many 
travelers serve as vectors to carry the infectious agent outside of the endemic areas (CDC, 
2009). The symptoms of this disease include fever, headache, malaise, and muscle aches. 
Some clinical signs of HME cases are easily to be separated from other diseases like 
HGA. For example, rash is easier to be found in HME cases (Dumler et al., 2005). Some 
severe cases of the diseases may involve infection to center nervous system. Diagnosis of 
human monocytic ehrlichiosis is mainly based on symptom and clinical signs of the 
disease and confirmatory laboratory test. Some indicatives of human monocytic 
ehrlichiosis in confirmatory laboratory test include low white blood cell count, low 
platelet count and elevated liver enzymes (CDC, 2009). Treatment with a tetracycline 
antibiotics and especially doxycycline has been shown effective for this disease 
(Hamburg et al., 2008). Much more details about HME will be discussed in the later 
paragraphs.  
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Ehrlichia chaffeensis, an emerging human infectious agent 
Discovery 
Ehrlichia chaffeensis, the causative agent of human monocytic ehrliciosis, is obligatory 
intracellular tick-transmitted rickettsiales bacteria in the family Anaplasmataceae of class 
Alpha Proteobacteria. The disease that the bacteria caused, which is called human 
monocytic ehrliciosis, was first found in April 1986 by a medical intern in Arkansas 
scanning the peripheral blood smear of patients (Maeda et al., 1987). Because the 
description of sustained tick-bitten experience by the patients, it was suspected as Rocky 
Mountain spotted fever (Fishbein, 1990; Maeda et at., 1987). Then, clinicians and 
scientists found that this infectious agent actually belongs to the genus Ehrlichia (Maeda 
et at., 1987). It was isolated in cell culture and characterized by molecular techniques at 
Fort Chaffee, Arkansas (Dawson et al., 1991), and because of that, it was named as 
Ehrlichia chaffeensis.  
 
Background 
This obligatory intracellular pathogen principally transmitted by the lone star tick 
Amblyomma americanum (Figure 1.4), and the major vertebrate mammalian host for this 
organism is the white-tailed deer (Figure 1.5) (Dawson et al., 1994; Lockhart et al., 1997; 
Parola et al., 2005; Anderson et al., 1993). Other vertebrates including humans, dogs, 
goats and coyotes may also be susceptible for serving as accidental hosts (Dugan et al., 
2000; Yabsley et al., 2004; Dugan et al., 2005; Yu et al., 2008). The life cycle includes 
propagation of the pathogen in its tick vector and vertebrate hosts. Larval or nymphal 
ticks get infected by the bacteria while they are feeding the infected vertebrate host and 
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then they transmit the pathogen to another healthy vertebrate host. Till now, no records 
have suggested that this pathogen can be transovarially transmitted (Long et al., 2003). 
HME cases are reported mostly from places where the lone star ticks and white-tailed 
deer are abundant (from New Jersey to Kansas and Southward) (Standaert et al., 1999; 
Bakken et al., 1996; Bakken et al., 1998; Dumler et al., 1998; Whitlock et al., 2000; 
Standaert et al., 2000; Olano et al., 2003; Paddock et al., 2003; McNabb et al., 2008). 
Recently, the incidence of human monocytic ehrlichiosis in the USA has increased 
gradually (Figure 1.6) (Paddock et al., 2003; McNabb et al., 2008), with an average of 
600 human cases of HME each year (McNabb et al., 2008). 
 
 
 
 
 
 
                   
 
Figure 1.4   Amblyomma americanum (Lone star tick) and its distribution. 
(source: http://www.cdc.gov/ncidod/dvrd/Ehrlichia/Natural_Hx/Natural_Hx.htm) 
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Figure 1.5 White-tailed deer. 
(source: http://fw.dpnr.gov.vi/education/AndyWebPage/Pictures/Mammals/digiscope029.jpg) 
 
 
 
 
 
 
 
 
 
 
Figure 1.6   Number of Ehrlichiosis cases (caused by Ehrlichia chaffeensis) reported to CDC by state 
health departments, 1999-2006. 
(Source: CDC National Electronic Telecommunications System for Surveillance (NETSS) data) 
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Clinical signs 
The clinical signs usually appear in 1-4 weeks after tick-bite (Parola et al., 2005). The 
symptom of this disease ranges from asymptomatic to mild flu-like symptoms, and 
sometimes might deteriorate into severe life threatening situation. The most common 
symptom includes malaise, fever, headache, muscle aches, chills, nausea and 
lymphadenopathy (Paddock et al., 2003; Dumler et al., 2007). Sometimes, it might also 
include cough, pharyngitis, swollen lymph nodes, vomiting, and possible changes in 
mental status. Unlike the Rocky Mountain spotted fever, only 30-40% of suspected cases 
reported having a rash associated with infection. Severe cases may include complications 
such as septic shock-like syndrome, meningitis, organ damage (Paddock et al., 2001; 
Stone et al., 2004; Dumler, 2005; Dumler et al., 2007). Leucopenia, thrombocytopenia, 
and an increase in hepatic transaminase levels are usually observable in the laboratory 
diagnosis (Paddock et al., 2003; Dumler et al., 2007). Although people of all ages are 
susceptible to the disease, it is reported that immune compromised people and elderly 
people have greater chance of getting infection (Figure 1.7) (Paddock et al., 2003; 
Gardner et al., 2003).   
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Figure 1.7  Age-specific incidence of Ehrlichiosis (caused by Ehrlichia chaffeensis), reported to CDC 
2001-2002 through NETSS. 
(source: http://www.cdc.gov/ticks/diseases/ehrlichiosis/statistics.html) 
 
Diagnosis and treatment 
Because other bacteria or virus also have similar symptom and clinical signs, definitive 
diagnosis during early stage of the disease is rather difficult. Thus, accurate description of 
tick-bite history and systematic laboratory diagnosis is very helpful to the preliminary 
confirmation of this disease (Dumler et al., 2007). Routine laboratory diagnostic methods 
for preliminary examination include detecting peripheral blood smear, performing IFA 
and PCR. Confirmatory examination usually involves cell culture of the pathogen 
(Anderson et al., 1991; Chapman et al., 2006; Dumler et al., 2007; Rikihisa et al., 2007). 
For prevention and clearance of the infection, treatment with tetracycline is proven to be 
very effective (Paddock et al., 2003). A derivative of tetracycline – doxycyline, which has 
been proved having better efficacy, is currently the drug of choice for treating HME 
(Dumler et al., 2007).  
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 Molecular biology 
Molecular biology of E. chaffeensis includes studies on 16S rRNA gene, DO/DeqQ 
family serine proteases, DsbA-like disulfide bond formation proteins, quinolinate 
synthetase A (NAD/A), VirB/D, a hypothetical protein (Esp73), fts Z gene, a variable 
length PCR target gene (VLPT), a homolog of heat shock protein gene (groESL), three 
glycoproteins(gp47, 120 and 156) and an abundantly expressed p28 kDa outer membrane 
proteins (p28-Omp) (Yabsley et al., 2003; Yu et al., 1997; Yu et al., 2000; Summer et al., 
1997; Summer et al., 1999, Singu et al., 2005; Rikihisa et al., 2007; Yu et al., 1997; Lee 
et al., 2003; McBride et al., 2002; Rikihisa et al., 2007; Seo et al., 2008). A brief 
description of several characterized genes is provided below.  
 
16S rRNA  
16S rRNA gene sequence has been reported from various E. chaffeensis isolates as an 
identical gene (Wen et al., 1997), and because of it is highly conserved, the 16S rRNA is 
used for other species differentiation and phylogenetic classification (Anderson et al., 
1991; Dumler et al., 2001). For example, PCR assays based on 16S rRNA gene and 
flowing PCR by RFLP is able to give a rapid discrimination between A. marginale, A. 
centrale and A. ovis (Vahid et al., 2009). PCR assays based on 16s rRNA gene and electro 
spray ionization mass spectrometry can be used to rapidly detect and identify Ehrlichia 
species in blood (Mark et al., 2010).  
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 The 28 kDa outer membrane proteins (p28-Omp) 
The 28 kDa outer membrane proteins of E. chaffeensis are encoded by a multigene locus 
containing 22 tandemly arranged paralogous genes (Reddy et al., 1998; Ohasi et al., 1998; 
Reddy et al., 1999; Yu et al., 2000; Cheng et al., 2003; Singu et al., 2005; Seo et al., 
2008). The molecular weights of mature proteins expressed from this multigene locus are 
predicted to be 28 kDa to 32 kDa, and because of that, it was named as the 28 kDa outer 
membrane proteins of E. chaffeensis. The amino acid sequence identity of these proteins 
is ranged from 20% to 83%. These arranged paralogous genes are separated by a 
fragment of 10 to 605 nucleotides non-coding intergenic sequences (Hotopp et al., 2006). 
Three highly variable regions present in all 22 genes which are significantly different in 
each gene (Reddy et al., 1998; Li et al., 2001; Li et al., 2002; Winslow et al., 2000). They 
are hydrophilic in nature and contain the immunogenic B-cell epitopes (Reddy et al., 
1998; Winslow et al., 2000; Li et al., 2001; Li et al., 2002).  
 
The p28-Omp locus genes of E. chaffeensis isolates also contain considerable variations 
(Cheng et al., 2003; Miura et al., 2007). According to the sequence variation, E. 
chaffeensis can be classified into three groups (I, II, and III) (Cheng et al., 2003). Ten 
isolates of E. chaffeensis recovered from human patients from various regions in the 
United States were used for this analysis.  Group I contains three isolates: Arkansas, 
Osceola, and Lithonia. Group II contains five isolates: St. Vincent, Chattanooga, West 
Paces, Heartland, and Wakulla isolates. Group III contains two isolates: Liberty and Jax 
(Cheng et al., 2003).  In addition, the p28-Omp gene 18 and p28-Omp gene 15 were 
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found in group I isolates and group III isolates, respectively (Cheng et al., 2003). 
Variations existing in the genome of different E. chaffeensis isolates may have some 
connection for overcoming host immune responses for continued persistence in its dual 
hosts. This hypothesis remains to be tested.  
 
E. chaffeensis p28-Omp multigene family in other species of Ehrlichia are also found 
(Gusa et al., 2001; Ohasi et al., 2001; van et al., 2004; Crocquet, 2005; Zhang et al., 
2008). For example, in E. ewingii and E. muris, the p28-Omp multigene locus has 19, and 
21 paralogous genes, respectively (van et al., 2004; Crocquet, 2005; Zhang et al., 2008). 
E. canis and E. ruminantium p28-multigene locus genus have different names, referred to 
as p30 Omp genes or MAP l genes (Ohasi et al., 2001; van et al., 2004). However, they 
are the paralogous of E. chaffeensis p28 Omp genes. The p-30 locus of E. canis includes 
22 tandemly arranged paralogous genes (Ohasi et al., 2001). Map 1/ p30 genes of E. 
ruminantium are 16 tandemly arranged paralogous genes (Brayton et al., 1997; Ohashi et 
al., 1998). 
 
Another feature of the p28-Omp multigene family is the existence of genes that encode 
for a putative transcriptional regulator and a secA gene (Ohasi et al., 2001; van et al., 
2004; Crocquet, 2006; Zhang et al., 2008).  The hypothetical transcriptional regulator of 
E. ruminantium is reported being polycistronically transcribed (van et al., 2004).  Recent 
studies from our laboratory also indicated the existence of transcriptional regulator in E. 
chaffeensis (Seo et al., 2008; Sirigireddy et al., 2005). The secA protein might be 
important in the process of translocation of bacterial outer membrane proteins to outer 
- 27 -  
membrane (Bernstein et al., 2000). The specific role of the putative transcriptional 
regulator and the secA gene in the p28-Omp multigene family of E. chaffeensis still needs 
to be studied.  
 
It is reported that multiple genes of the p28-Omp multigene family are transcriptionally 
active in E. chaffeensis originating from the macrophages (Yu et al., 2000; Ohasi et al., 
2001; Long et al., 2002; Unver et al., 2002; Cheng et al., 2003; Seo et al., 2008). 
However, the major expressed transcriptional protein in vertebrate cells is p28-Omp 19 
(Cheng et al., 2003; Seo et al., 2008), and it is also reported that gene 14 of the p28-Omp 
multigene family is transcriptionally active in E. chaffeensis originating from tick cells or 
infected ticks (Unver et al., 2001; Unver et al., 2002).  Similar differential expression for 
E. canis and E. ruminantium (Ohasi et al., 2001; Unver et al., 2001; Bekker et al., 2002; 
van et al., 2004).  
 
Recent proteomic analysis from our laboratory further confirmed the predominant protein 
expression of p28-Omp gene 19 from vertebrate macrophages and the predominant 
protein expression of the p28-Omp gene 14 from tick cells (Singu et al., 2005; Singu et 
al., 2006; Seo et al., 2008). This host-specific predominant expression has also been 
reported in the p28-Omp locus homologues of E. canis (Unver et al., 2001; Felek et al., 
2003; Singu et al., 2006).  The vertebrate macrophages and tick cells host-specific 
predominantly expression might be an important mechanism to explain immune evasion 
and continued persistence of the pathogen in different hosts.  
 
- 28 -  
 120 kDa surface protein 
The 120 kDa surface protein is a potential adhesin of E. chaffeensis (Yu et al., 2000). It is 
one of the major immunoreactive proteins for which antibodies were detected in most 
patient sera with HME infection and E. canis infected dogs (McBride et al., 2000; Yu et 
al., 1997; Yu et al., 2000). The 120 kDa surface protein gene of Arkansas isolates of E. 
chaffeensis has four identical tandem repeats and each repeats is 240 bp in length. This 
gene feature shows great divergence between different Ehrlichia species, both in the 
number of the tandem repeats and the amino acid sequence of the repeats (Yu et al., 
1997). In addition, all of the major immunoreactive tandem repeat proteins are highly 
acidic due to a predominance of glutamate/aspirate and also they seems to be serine rich 
within tandem repeats of the proteins (Doyle et al., 2006; Luo et al., 2008). The 120 kDa 
surface proteins are differently expressed by dense-cored E. chaffeensis and are found on 
the surface of the organism (Popov et al., 2000). It is reported that these surface proteins 
interact with important host cell targets and facilitate pathogen survival (Wakeel et al., 
2009). However, the specific role of this protein in pathobiology and protective immune 
response is still undefined.  
 
Variable Length PCR Target gene (VLPT) 
VLPT is another immunoreactive protein of E. chaffeensis and it can be used for 
detection and differentiation of E. chaffeensis strains (Sumner et al., 1999).  The VLPT of 
Arkansas strain of E. chaffeensis is 44 kDa in molecular mass and the open reading frame 
(ORF) contains four 90 bp imperfect tandem repeats (Sumner et al., 1999). The number 
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of repeats is also not the same in different isolates of E. chaffeensis (Sumner et al., 1999, 
Cheng et al., 2003). For example, the Wakulla strain has a six-repeat version of the 
variable-length PCR target gene, whereas the Arkansas and Liberty strains have four 
repeats (Sumner et al., 1999). Compared to 120 kDa surface proteins, VLPT genes have 
more tandem repeats which make it more useful for strains differentiation (Yabsley et al., 
2003). However, the exact role of VLPT in E. chaffeensis pathogenicity still remains to 
be known.  
 
Heat Shock Gene Operon (groESL) 
E. chaffeensis homologs of Escherichia coli heat shock gene operon (groESL) contains a 
stress-inducible promoter, followed by a GroES open reading frame which encodes a 
protein with molecular mass of 10-20 kDa, and a GroEL open reading frame which 
encodes a protein with molecular weight of 58-65 kDa (Sumner et al., 1993). GroES and 
GroEL genes are separated by noncoding sequences and these sequences vary in length in 
different bacteria (Sumner et al., 1993). GroEL has been called the bacterial common 
antigen and is related to the HSP 60 family of heat shock proteins (Rikihisa et al., 2007). 
Heat shock proteins of bacteria serve to protect cells under stressful condition and 
environment (Lindquist et al., 1988; Jenkins et al., 1988). However, the exact role of 
GroESL of E. chaffeensis is still not well studied. 
 
Immunologic aspects of Ehrlichia chaffeensis infection 
The possibility of getting infection by infectious agents depends on several factors, such 
as the age of an animal, or a specific host species, the virulence of a pathogen and the 
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immune status of the host. Usually, the pathogen intrusion might not indicate the 
necessary clinical signs of the disease, and the infection level may vary according to the 
host immune status. For example, the E. chaffeensis infection in humans is shown to be 
more severe in children, elderly and immune compromised people (Safdar et al., 2002; 
Paddock et al., 2003; Gardner et al., 2003), but very mild in the healthy adults. It is 
reported that E. chaffeensis can persist inside of healthy immune competent people, but it 
usually appears with no clinical sign (Davidson et al., 2001). 
 
According the status of immune system of host, the responses for a pathogen intrusion 
may vary from a clinical disease, clearing of clinical signs and possibly even clearing the 
pathogen (Marshall et al., 2002; Yevich et al., 1995).  For better understanding the host 
response of E. chaffeensis, several studies has been carried out since the discovery of the 
pathogen (Barnewall et al., 1994; Lee et al., 1996; Winslow et al., 1998; Winslow et al., 
2000; Winslow et al., 2003; Ganta et al., 2002; Ganta et al., 2004; Ganta et al., 2007; 
Chapes et al., 2008). Recently, murine models has been proven very useful for illustrating 
the host immune mechanism against E. chaffeensis infection  (Winslow et al., 1998; 
Winslow et al., 2000; Winslow et al., 2003; Ganta et al., 2002; Ganta et al., 2004; Ganta 
et al., 2007; Chapes et al., 2008).  
 
In the early experiment of using murine models, immunocompetent mice clear the E. 
chaffeensis infection within 10-17 days post infection (Winslow et al., 1998), but immune 
deficient (SCID) mice who lack T- and B-cells fail to clear the infection of pathogen, and 
finally SCID mice exhibit severe clinical signs (Winslow et al., 1998). This proves that T-
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cells and B-cells play vital role in clearing the infection of E. chaffeensis (Winslow et al., 
1998; Ganta et al., 2002; Ganta et al., 2004). In another experiment, major 
histocompatibility complex-II (MHC-II) deficient mice fail to clear the infection of E. 
chaffeensis (Ganta et al., 2002; Ganta et al., 2004), and the persistence of the pathogen in 
mice last for as long as 92 days (the longest time evaluated) (Ganta et al., 2002; Ganta et 
al., 2004).  Similar results are obtained from toll-like receptor 4 (tlr4) deficient mice and 
it shows that the persistence of E. chaffeenis can last as long as 30 days (Ganta et al., 
2002; Ganta et al., 2004). All the data indicate that major histocompatibility complex-II 
and toll-like recptor 4 are very important factor involving in the host immune response to 
E. chaffeensis infection. 
 
Antibodies play a significant role in clearance of the pathogen. It is reported that SCID 
mice can be protected from a severe E. chaffeensis infection if injected with immune 
serum from E. chaffeensis infected immunocompetent mice (Winslow et al., 2000). The 
protection time can last for up to 70 days if repeated injected with immune serum 
(Winslow et al., 2000; Li et al., 2001). Antisera against E. chaffeensis are predominantly 
made against outer membrane expressed proteins (Seo et al., 2008). Although antibodies 
are known to play critical role in immune response to clear E. chaffeensis infection, they 
alone are not sufficient to clear the pathogen (Seo et al., 2008). In particular, various 
subsets of T-cells and cytokines are needed for effective clearance of the infection (Li et 
al., 2001; Winslow et al., 2000).  
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Some subsets of T-cells have been proven to be important for immune response to E. 
chaffeensis infection (Ganta et al., 2002; Ganta et al., 2004; Bitsaktsis et al., 2004; 
Bitsaktsis et al., 2006; Nandi et al., 2007; Ismail et al., 2007; Bitsaktsis et al., 2007; 
Chapes et al., 2008). Helper T-cells deficient MHCII knockout mice can not clear the 
infection of E. chaffeensis for several months (Ganta et al., 2002; Ganta et al., 2004). The 
time of clearing the pathogen has been delayed for about two weeks in CD4+ helper T-
cell deficient mice (Ganta et al., 2002; Ganta et al., 2004). This result indicates that 
helper T-cells are very important factor for host immune response for E. chaffeensis. It is 
also reported that γδ T-cells are found to be present in peripheral blood of E. chaffeensis 
infected human patients (Caldwell et al., 1996; Caldwell et al., 1996). The result 
indicates that γδ T-cells may be an important factor for immune response for this 
pathogen.    
 
Other factors of host immune system might play minimum role for E. chaffeensis 
infection. For example, both CD4+ T-cells deficient mice and CD4+ T-cells deficient 
MHCII knockout mice exhibit a minimal CD8+ T-cells activity after  E. chaffeensis 
infection (Ganta et al., 2004); and β2 microglobulin (β2M, a structural component of 
MHCI)-knockout mice also exhibit a complete clearance of the infection of E. chaffeensis 
(Chapes et al., 2008). The findings indicate that CD8+ T-cells are a minor factor in host 
immune clearance for the pathogen. This applies for NKT cells as well. The SCID mice 
that are deficient for T-cells and B-cells but contain functionally normal NKT cells 
exhibit persistent infection of E. chaffeensis (Winslow et al., 1998). The NKT cells are 
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functionally normal, but E. chaffeensis is persistently existed in mice (Chapes et al., 1993; 
Ganta et al., 2002; Ganta et al., 2004). 
 
Some immunomodulating agents are involved in the clearance of the infection of E. 
chaffeensis. It is reported that suppression of several proinflammatory cytokine 
expression, including IL-1α, IL-4, IL-6, IL-12, IL-15, and IL-18 occurs in E. chaffeensis 
infected human monocytic cell lines (THP1 cells) (Zhang et al., 2004). These cytokines 
are involved in early inflammatory response for the intrusion of the pathogen (Dinarello, 
2000).   Suppression of these cytokines will facilitate E. chaffeensis to escape from being 
killed by NKT cells and cytotoxic T-cells, and colonize inside the macrophages or 
monocytes (Dinarello, 2000). Cytokines IL-15 and IL-18 usually serve as activators for 
CD4+ T-cells to produce IFN-γ and activate macrophages mediated killing of the 
pathogen (Barnewall et al., 1994; Liew et al., 2002; Bitsaktsis et al., 2004). Thus, 
cytokines are in part a critical factor in immune response for E. chaffeensis infection. 
 
The entire immune system works in a network way, and if one subset of T-cells is absent, 
the other subsets of T-cells will compliment its function. The experiments of intracellular 
bacteria of Mycobacterium tuberculosis and Francisella tularensis illustrate this 
phenomenon. When CD4+ T-cells deficient mice are attacked by pathogens, other T-cells 
such as CD4- T-cells, CD8- T-cells, and natural killer T-cells will compliment for the 
CD4+ T-cell deficiency and work together to help clear the pathogens (Rahemtulla et al., 
1994; Cowley et al., 2003; Cowley et al., 2005; Mattner et al., 2005). It is also reported 
that components of immune system including antibodies, macrophage activation, 
- 34 -  
involvement of several T-cell subtypes and cytokines work together to clear E. 
chaffeensis infection (Barnewall et al., 1994; Lee et al., 1996; Winslow et al., 1998; 
Winslow et al., 2000; Ganta et al., 2002; Ganta et al., 2004). Thus, network of different 
components of immune system serves as the effective solution for the immune system of 
the host in the clearance of E. chaffeensis. 
 
Electromicroscopy 
Under electromicroscopy, two morphological forms of E. chaffeensis can be observed 
residing within the intracellular parasitophorous vacuoles (morulae) in macrophages: 
dense-cored cells (DC) (0.4–0.6 μm) and reticulate cells (RC) (0.4–0.6 μm by 0.7–1.9) 
(Popov et al., 1995; Zhang et al., 2007) (Figure 1.8). DCs are smaller than RCs and they 
contain highly dense nucleotide inside; RCs contain uniformly dispersed nucleotide 
filaments and ribosome (Popov et al., 1995). Some RCs form long projections of the cell 
wall and these projections protrude the cytoplasmic membrane into the periplasmic space, 
budding protoplast fragments into the periplasmic space (Popov et al., 1995; Zhang et al., 
2007). Both DC and RC forms replicate themselves by binary fission inside the cells. In 
the beginning of their infectious cycle, usually 24 h after infection, DC usually transform 
into RC form. In the end of each cycle, the RCs transform back into DCs in the 
phagosome and they are released from monocytes or macrophages (Zhang et al., 2007). 
This type of cycle, transforming from dense core to reticulate forms and then back to 
dense core forms, is very typical for the genera Ehrlichia and Anaplasma (Ashley et al., 
1975; Hodinka et al., 1988; Wolf et al., 2000; Wyrick, 2003).  DCs and RCs are also 
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found in the phagosome of infected tick cells (Ganta et al., 2009). In tick cells, however, 
both DCs and RCs can exist within the same phagesome (Ganta et al., 2009). 
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Figure 1.8   Two morphological forms of E. chaffeensis (Ganta et al., 2009). 
 
 
 
Pathogen persistence  
The pathogens of tick-transmitted diseases usually persist in their host for long time and 
cause severe infection. For example, Borrelia burgdorferi causes Lyme diseases in human, 
dogs and many other animals (CDC, 2010); protozoan parasite Babesia microti causes 
infection of human babesiosis in the USA (CDC, 2010);  Francisella tularensis causes 
infection of tularemia in human (CDC, 2010); and Rickettsia rickettsia causes Rocky 
Mountain spotted fever to human (CDC, 2010). For an intracellular bacterium, like E. 
chaffeensis, the critical steps to establish effective infection usually include: attachment, 
internalization and intracellular multiplication (Rudel et al., 1992; Giron et al., 2002;  
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Okamoto et al., 2004, Zhang et al., 2004).  E. chaffeensis lacks the specialized structures 
to attach and internalize, but it is reported that the 120 kDa surface protein appears to 
serve as adhesion (Popov et al., 2000). Nonetheless, it is unclear how this pathogen is 
phagocytosed by the host monocytes or macrophages, and it is also not clear how E. 
chaffeensis can overcome the phagosomal clearance and adapt itself to the host for 
keeping persistent infection. The mechanism of persistent infection and the reasons for 
the host immune system failure to clear the infection are not well understood. 
 
One important hypothesis is that differential gene expression may be an important 
adaptative mechanism used by E. chaffeensis in support of its continued survival. Recent 
studies from our laboratory showed that the protein expression of E. chaffeensis from tick 
and vertebrate host cell environment has significant differences, especially the outer 
membrane proteins of the p28-Omp multigene family. Proteins of the gene 14 of the p28-
Omp locus were found predominantly expressed in tick host, and proteins of gene 19 of 
the p28-Omp locus were found predominantly expressed in vertebrate host. Much of the 
fundamental knowledge of the pathogen’s persistence and its host specificity can be 
better understood by performing mutational analysis on the critical genes of the p28-Omp 
multigene family of E. chaffeensis.  
 
Several methods have been documented and proven to be useful in creating effective 
gene mutations in both gram positive and gram negative bacteria, including in Rickettsial 
agents. For example, transposon-based mutagenesis has been applied for Rickettsia and 
Anaplasma species (Qin et al., 2004; Liu et al., 2007). Homologous recombination based 
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mutagenesis is extensively used in Esherichia coli and many other bacteria 
(Kowalczykowski et al., 1994; Messerle et al., 1997; Nowosielska et al., 2006). However, 
the transformation in E. chaffeensis is complicated as it is an intracellular obligate 
pathogen and the host cell free bacteria have shorter life spam (Paddock et al., 2003). 
Methods like transposon based mutagenesis is usually targeted randomly, thus it is not 
appropriate to use it as the mutagenesis to knockout specific genes such as the genes of 
p28-Omp locus of E. chaffeensis. Although the homologous recombination based gene 
knockout system is a method specifically for targeting in one or several gene sites, this 
gene mutation method is not studied in detail in E. chaffeensis. 
 
Creating gene mutation in E. chaffeensis  
Targetron gene knockout system (mobile group II introns) is a novel gene mutagenesis, 
which can be programmed to insert into any desired DNA target site with high specificity 
(Guo et al., 2000; Karberg et al., 2001). Mobile group II introns use a remarkable 
mobility mechanism mediated by a ribonucleoprotein (RNP) complex which contains the 
intron-encoded protein (IEP) and the excised intron RNA (Lambowitz et al, 1999). 
Because most of the target specificity comes from base-pairing of the intron RNA to the 
target DNA sequence, it is possible to reprogram group II introns to insert into desired 
sites simply by modifying the intron RNA (Guo et al., 1997). This feature combined with 
their very high insertion frequencies and specificity made it easy to create specific gene 
mutation on any organism. This method has been utilized successfully for E.coli, Shigella 
flexneri, Salmonella typhimurium, Lactococcus lactis, Clostridium perfringens, 
Staphylococcus aureaus, and Francisella tularensis (Yao et al., 2006; Cui et al., 2007; 
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John et al., 2007; Rodrigurez et al., 2008). We believe that the Targetron gene knockout 
system may also be applied to study key genes of E. chaffeensis including p28-Omp 
multilocus genes. 
 
Introduction: Group II intron and Targetrons 
Group II intron is a class of intron existing in rRNA, tRNA, mRNA of organelles in fungi, 
plants, protists, and mRNA in bacteria (Dai et al., 2003). They were first discovered in 
the organellar mitochondrial and chloroplast genomes of lower eukaryotes and higher 
plants (Michel et al., 1989). The bacterial group II introns were identified about 17 years 
ago by PCR screens (Ferat et al., 1993). Then, genome sequencing revealed that group II 
introns are very common in both gram-negative and gram-positive bacteria (Dai et al., 
2003). Later, group II introns have been found in Methanosarcinales (Toro et al., 2003; 
Dai et al., 2003; Rest et al., 2003). Recently, mobile group II introns have been used to 
develop a new type of gene-targeting method- Targetron Gene Knockout System 
(Lambowitz et al., 2004). 
 
Structures of Group II Introns 
 
Group II introns generally contain 6 domains (Domain I to Domain VI) (Figure 1.9), in 
which Domain I, Domain V, and Domain VI are involved the splicing reaction, Domain 
II and Domain III are involved in stabilization of proper folded structures, and Doman IV 
is involved in folding or catalytic activity. Domain I is the largest and most complex 
domain, in which the sequences of exon-binding sites 1 and 2 (EBS1 and EBS2) bind 
specifically to the sequences of intron-binding sites 1 and 2 (IBS1 and IBS2). Domain V 
is a small hairpin with a bulge in the stem and it contains a loop which is essential for 
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interaction with Domain I. It is suggested that Domain V is an essential catalytic 
component of the active ribozyme, and this domain can induce splicing reaction in 
special conditions (Qin et al., 1998). Domain VI contains a bulging “A” residue which is 
a branch point to the 5’ exon when splicing. Domain IV contains ORF expressing the 
intron-encoded protein (IEP) gene, and IEP is known to play an essential role in helping 
in vivo folding of the intron RNA into a catalytic active structure (Belfort et al., 1995; 
Zimmerly et al., 1995). The IEP includes four conserved domains: a N-terminal RT 
domain, a domain termed ‘X’ which is a putative RNA-binding domain associated with 
RNA splicing activity, a C-terminal DNA- binding domain, and a DNA- endonuclease 
domain. It is believed that the IEP is translated from a ‘pre-mRNA’ and later processed to 
the mature protein (Anziano et al. 1982; Carignani et al. 1983).  
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Generic secondary structure of group II intron RNA and domain structure of the intron-
encoded proteins (IEP) (Zhong et al., 2003). 
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Retrohoming Mechanism  
The mobility of group II introns is first demonstrated for the S. cerevisiae coxI-I1 introns 
(Meunier et al., 1990) and the related Kluyveromyces lactis coxI-I1 introns (Skelly et al., 
1991). Then, it was reported that an efficient E.coli expression system for Lactococcus 
lactis Ll.LtrB intron has been constructed and group II introns could function as mobile 
genetic elements by inserting directly into target sites in double stranded DNA (Matsuura 
et al., 1997). This mobility is mediated by the multifunctional IEP, which shows reverse 
transcriptases (RTs), maturase, and DNA endonuclease activities (En) activities.  
 
Retrohoming occurs through a target DNA-primed reverse transcription mechanism 
(Figure 1.10) which involves several sequential reactions. First, RNP initiates mobility by 
recognizing a specific double-stranded DNA target site, with both the IEP and base 
pairing of the intron RNA contributing to DNA target site recognition. Then, the IEP 
interacts with a few bases in the distal 5’ exon region via major groove and phosphate-
backbone interaction, and triggers local DNA unwinding in the same time to facilitate the 
intron RNA base pairing with the adjacent 14–16 nt local DNA sequence. These base 
pairing interactions involve three short sequence elements in the DNA target sites: IBS2 
and IBS1 and δ′, and they are recognized by three complementary sequence elements: 
EBS1 and EBS2 and δ in the intron RNA. After binding, the RNA component of the RNP 
cleaves the sense-strand precisely at the exon junction in the double-stranded DNA, and 
IEP uses its endonuclease domain (En) to cleave the antisense-strand at position +9 
relative to the insertion site. The 3’ end of the cleaved antisense-strand is then targeted as 
- 41 -  
a primer for reverse transcription, generating a cDNA strand that is subsequently 
incorporated into the recipient DNA primarily by recombination mechanisms 
(Lambowitz et al., 2004). This mechanism can be used to develop the novel gene 
mutagenesis- Targetron Gene Knockout System. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10  Mechanism of DNA target site recognition by the Ll.LtrB group II intron (Zhong et al., 
2003). 
 
 
Applications of Targetron Gene Knockout System 
Targetron Gene Knockout System is the commercial name of the technology, and it could 
be used to insert into any desired target DNA and knockout a number of genes. Due to its 
high efficiency and high specificity, Targetron Gene Knockout System has been 
successfully applied into gene mutation or modification in plentiful of bacterial species. 
Also, this technology significantly reduced the time needed for disrupting a gene, 
compared with conventional homologous recombination methods. For example, 
Staphylococcus aureus, which acquired antibiotic resistance, is a serious and increasing 
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clinical disease (CDC, 2001; CDC, 2005). In Staphylococcus aureus, hsa gene encodes a 
member of the HU family of bacterial histone-like proteins and seb encodes eterotoxin B 
(Yao et al., 2006). Creating site-specific mutations in this gram-positive bacterium 
targeting at the hsa and seb genes by using conventional homologous recombination is 
rather difficult. However, the hsa and seb genes were disrupted efficiently with Targetron 
Gene Knockout System (Yao et al., 2006). In higher organisms, group II introns were 
designed and selected to insert into HIV1 provirus and the human gene encoding CCR5, 
an important target site in anti-HIV therapy (Guo et al., 1997). The retargeted intron 
RNPs retained activity in human cells, inserting into plasmid-borne HIV1 and CCR5 
target sites after liposome-mediated transfection (Guo et al., 1997).   
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Ehrlichia chaffeensis, an intracellular tick-transmitted rickettsial, is the agent of an 
infectious disease termed human monocytic ehrlichiosis (HME). The infection results in 
symptoms that vary from asymptomatic infection to severe life threatening disease with a 
mortality of about 3% (Paddock et al., 2003).  Recently, the incidence of HME in the 
USA has increased (Paddock et al., 2003; McNabb et al., 2008) with an average of 600 
reported cases each year (McNabb et al., 2008). The estimated cases may be significantly 
higher by at least four times more than the reported cases (CDC, 2007). One of the 
striking features of this disease causing agent is its dual host life cycle and prolonged 
persistence in both tick and vertebrate hosts. The mechanism of this persistent infection 
and the reasons for the host immune system failure to clear the infection is not clear.  
 
There may be several ways by which the pathogen could persist. One important 
hypothesis is that differential gene expression may be an important adaptative mechanism 
used by E. chaffeensis in support of its continued survival in its dual hosts. Recent studies 
from our laboratory also support this hypothesis. Protematic analysis showed that the 
proteins of E. chaffeensis from tick and vertebrate host cell environment differed 
significantly. The differentially expressed proteins include many outer member proteins. 
An outer membrane protein from the p28-Omp mutigene locus gene p28-Omp 14 was 
found to be predominantly expressed in tick host and protein of the p28-Omp 19 gene 
was found to be the major expressed protein in vertebrate host environment. The 
differential expression was also confirmed in the bacteria under in vivo conditions in ticks 
and vertebrate hosts. Much of the fundamental knowledge of the pathogen’s persistence 
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and its host specificity may be better understood by performing mutational analysis on 
the critical genes of E. chaffeensis.  
 
Studies to date on E. chaffeensis lead to considerable progress in identifying the 
differential expression of many proteins in a host cell specific manner. The recent studies 
also aided in understanding the host immune response needed for clearing the pathogen 
in a vertebrate host. In particular, studies suggest that E. chaffeensis can be cured rapidly 
if it originates from vertebrate macrophages, but the clearance may be delayed if the 
organism replicates in tick cell environment. These observations, together with host cell-
specific differential expression, suggest that the altered pathogen gene expression in tick 
cell environment may provide an opportunity to persist in a vertebrate host. Similarly, the 
pathogen originating from vertebrate macrophages may persist in ticks. This may be 
important strategy for the pathogen’s continued life cycle in vertebrate and tick hosts. The 
above stated hypothesis is exciting, however, at this time we do not have molecular tools 
to test it. Importantly, there are no established methods to create mutations in E. 
chaffeensis, assessing the functional significance of differentially expressed protein. 
 
Several methods have been documented and proven to be useful in creating effective 
gene mutations in both gram positive and gram negative bacteria, including in Rickettsial 
agents. For example, transposon based mutagenesis has been applied for Rickettsia and 
Anaplasma species (Qin et al., 2004; Liu et al., 2007). Homologous recombination based 
mutagenesis is extensively used in Esherichia coli and many other bacteria 
(Kowalczykowski et al., 1994; Messerle et al., 1997; Nowosielska et al., 2006). 
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Nonetheless, these approaches have not been tested for E. chaffeensis. One of the 
challenging with E. chaffeensis is its obligate parasitic life and the pathogen has a limited 
survival outside a host cell. The focus of this study is to fill in this gap of knowledge by 
evaluating mutational methods. We opted to evaluate a relatively recently established 
method, ‘TargeTron Gene Knockout System’ for creating mutations in E. chaffeensis. 
This method utilizes the target specific insertions using modified group II intron. This 
method was effective in creating mutations in a wide range of gram positive and gram 
negative bacterial organisms. The justification for using this method is that the Group II 
intron can be programmed for insertion into virtually any desired DNA target with 
possibly high frequency and specificity. We focused this study with the objective to create 
mutations in E. chaffeensis at three genomic regions. 
 
 
 
 
 
 
 
 
 
                                              Materials and methods 
 
 
1  Target site selection and primer ordering 
The sequences of Ech_1136 (p28-Omp gene 14), Ech_1143 (p28-Omp gene 19) and 
Ech_0126 (p28-Omp gene 126) of E. chaffeensis downloaded from GenBank were used 
in preparing primers for retargeting group II intron with the aid of the TargeTron Design 
Site software (www.sigmaaldrich.com/targetron). The primer sets (IBS, EBS2, and 
EBS1d) that are likely to be most effective in the insertion mutations were ordered from 
Sigma Aldrich Company. 
 
2  PCR for Group II intron re-targeting  
2.1 Primer preparation 
The IBS and EBS1d primers were diluted to 100 μM, and the EBS2 primer was 
diluted to 20 μM, in nuclease free water. These three primers (one set each for each 
gene retargeting) were mixed with the fourth universal primer, EBS universal primer, 
to prepare a mix for overlapping PCR as show in Figure 2.1: 
                                                         Primer Mix  
2 μl IBS primer (100 μM) 
2 μl EBS1d primer (100 μM) 
2 μl EBS2 primer (20 μM) 
2 μl EBS universal primer (20 μM) 
12 μl Nuclease free water 
20 μl Total volume 
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Figure 2.1   Overlapping PCR for group II intron retargeting. 
 
2.2 PCR reaction set up and thermorcycling 
Amplification reactions were performed using the four primer mixes specific for each 
gene target and group II intron PCR template (Sigma, St. Louis, MO) by preparing 
the mixes and temperature cycles outlined below. 
PCR reaction mixture 
23 μl water (molecular biology reagent) 
1 μl Four-primer mix (Lac Z control or specific primers for your target site) 
1 μl Intron PCR template 
25 μl JumpStart REDTaq Readymix 
50 μl Total volume 
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Temperature cycles 
Initial denaturation 94 ℃ for 30 sec 
30 cycles  
Denaturation 94℃ for 15 sec 
Annealing 55℃ for 30 sec 
Extension 72℃, 30 sec 
Final extension 72℃, 2 min 
Soak 4℃ 
 
2.3 Agarose gel electrophoresis  
The PCR products were resolved in a 0.9 % agarose gel in 1X TAE buffer (40 mM Tris-
acetate, 1 mM EDTA; final pH 8.0) containing 0.1 μg/ml of ethidium bromide by 
subjecting to 120 V of electricity for 1.5 h. The presence of 0.35 kb amplicons were 
identified with the aid of resolved molecular reagent markers. Agarose gel preparation 
and electrophoresis were performed by following instruction outlined in the volume 1 of 
the third edition of Molecular Cloning (Joseph et al., 2001). 
 
2.4   Phenol purification of the PCR products and restriction enzyme digestions   
PCR products were purified by following phenol:chloroform:isoamylalcohol and ethanol 
precipitation method (Joseph et al., 2001). Briefly, to 40 μl of PCR products, sodium 
acetate was added to a final concentration of 0.3 M. Two hundred μl of phenol (pH 8.0) 
was mixed to the PCR product and salt mix, vortexed and spun at 15,000 g for 5 min and 
aqueous layer was transferred to a clean 1.5 ml micro centrifuge tube. The organic 
extraction step was repeated two more times: one with phenol:chloroform:isoamylalcohol 
(25:24:1) and one with chloroform:isoamylalcohol (24:1). To the final resolved aqueous 
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layer, 500 μl of 100% ethanol was added and vortexed to mix the contents, and incubated 
at -20°C for 15 min followed by centrifugation at 15,000 g for 15 min.  The supernatant 
was discarded and the DNA pellet was rinsed with 0.5 ml of 70% ethanol.  The final 
pellet was air dried, resuspended in 20 μl TE buffer (pH 8.0) and stored at -20°C until use. 
Purified PCR products were digested with Hind III and BsrG I (Note: These restriction 
sites were created by inserting the R.E. recognition sequence in the 5’ end of IBS, and 3’ 
end of EBS1d primers, respectively) under the conditions outlined in the table below. 
 
2 μl 10X N.E. Buffer 2 
8 μl  purified PCR products (about 200 ng) 
1 μl BsrG I 
1 μl Hind III 
0.2 μl BSA (100 μg/ ml) 
8 μl Nuclease free water 
20 μl Final volume 
 
The reaction was incubated for 30 min at 37℃, 30 min at 60℃ and 10 min at 80℃, 
sequentially. 
 
One hundred ng of pACD4K-C plasmid DNA obtained from Sigma Aldrich company 
was also digested with with Hind III and BsrG I under conditions outlined in the table 
below. 
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2 μl 10X N.E. Buffer 2 
5 μl  pACD4K-C plasmid DNA (100 ng) 
1 μl BsrG I 
1 μl Hind III 
0.2 μl BSA (100 μg/ ml) 
11 μl Nuclease free water 
20 μl Final volume 
 
The reaction was incubated for 30 min at 37℃, 30 min at 60℃ and 10 min at 80℃, 
sequentially. 
 
3  Construction of pACD4K-C- gene 14/ gene 19/ gene 126 vector 
3.1 Ligation reactions 
The R.E. digested pACD4K-C plasmid DNA was resolved on a 0.9 % agarose gel 
(Joseph et al., 2001) and 6.9 kb fragment of a gel was isolated and purified by 
phenol:chloroform:isoamylalcohol and precipitation method (as described previously). 
Final purified DNA was resuspended in TE buffer (10 mM Tris and 1 mM EDTA at pH 
8.0) to the final concentration of 20 ng/ml. Hind III and BsrG I digested PCR products 
was also purified by phenol:chloroform:isoamylalcohol and precipitation method. 
Subsequently, the PCR DNA and isolated pACD4K-C plasmid DNA segment were used 
in the ligation reaction outlined below. 
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2 μl pACD4K-C linear Vector (40 ng) 
1 μl BsrG I/ Hind III-digested intron PCR  product (10 ng) 
1 μl 10X T4 DNA liagase buffer 
1 μl T4 DNA liagase (Promega, Madison) 
5 μl Nuclease free water  
10 μl Total volume 
Ligate at 16 ℃ for overnight 
 
3.2 Transformation in E. coli and selection of positive clones  
Two hundred μl of chemical competent cells of E. coli are mixed with 50 μl of 100 mM 
CaCl2 and 49 μl of sterile water. One μl of ligation products were added to this 
suspension and mixed well by gentle tapping at the bottom of the tube. The contents were 
incubated on ice for 15 min, followed by a heat shock at 42°C for 2 min. The cells were 
incubated at room temperature for 10 min, added 1 ml of LB medium, and incubated at 
37°C in a shaker incubator for 1 h. Two hundred μl of culture were transferred onto LB 
agar plates containing 25 mg/ml chloramphenicol, and also including 30 μl each of 20 
mg/ml X-Gal and 100 mM IPTG spreaded onto the plates.  The plates were incubated 
overnight in a 37°C incubator. White colonies were randomly selected and screened for 
the presence of retargeted insert containing pACD4K-C plasmids.  
 
3.3 Extraction of Plasmid DNA 
Plasmid DNAs were extracted by boiling preparation method (Joseph et al., 2001) from 
white colony cultures grown in LB medium with chloramphenicol (25 µg/ml). Briefly, 
1.5 ml of overnight grown bacterial cultures was transferred into micro-centrifuge tubes 
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and centrifuged 12,000 g for 5 min. The supernatant was aspirated carefully and cell 
pellet was resuspended in 0.4 ml plasmid lysis buffer (10mM Tris-HCl pH 8.0, 0.1 M 
NaCl, 1mM EDTA, 5% v/v Triton X-100).  Twenty five μl of freshly prepared lysozyme 
(10 mg/ml) in 10 mM Tris-HCl buffer (pH 8.0) was added.  The contents of the tube were 
vortexed for few sec to mix, placed in a boiling water bath exactly for 40 sec, and 
centrifuged at 12,000 g for 15 min at 4°C.  The pellet containing cell debris was removed 
with the help of a tooth pick. Four hundred and twenty μl of cold (-20°C) 100%  
isopropanol was added to the supernatant and mixed by vortexing, incubated at room 
temperature for 5 min and centrifuged at 12,000 g for 15 min to recover plasmid DNA.  
Supernatant was discarded and the DNA pellet was rinsed with 1 ml of 70% ethanol and 
dried in a speed-vac system (Labconco Centrivap Concentrator, Kansas City, MO) 
typically for about 5 min. Final pellet was resuspended in 100 μl of TE buffer and 
contaminating bacterial RNA was removed by treating with 1 μl of RNase A (1 mg/ml) at 
37°C for 5 min. The quantity and quality of the plasmid DNA were checked by agarose 
gel electrophoresis.  
 
3.4 Confirmation by Restriction Enzyme reaction 
The extracted plasmids (5 μl each) were digested with BsrG I and Hind III enzyme 
similar to the method outlined previously. The clones with the correct inserts were 
selected for sequencing analysis to verify mutation in the modified group II intron 
segments. 
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3.5 Confirmation by Sequencing 
The final constructs of pACD4K-C-Ech_1136 (p28-Omp gene 14), pACD4K-C-
Ech_1143 (p28-Omp gene 19) and pACD4K-C-Ech_0126 (p28-Omp gene 126) (all three 
constructs are also called pACD4K-C-gene 14/gene 19/gene 126) were sequenced by 
gene analytic system, using T7 primer (forward primer) and one gene specific primer 
(IBS or EBS1d). The protocols for sequencing analysis were followed as described in the 
CEQ 2000 Dye Terminator Cycle Sequencing with Quick Start Kit manual (Beckman 
Coulter, CA). Sequences were manually evaluated to confirm mutations specific for 
targeting genes _1136 (gene 14), Ech_1143 (gene 19) and Ech_0126 (gene 126).  
  
4   Cloning the tuf promoter into a promoterless vector, pBlue-TOPO 
4.1   Cloning tuf promoter 
RRG725 (tuf-Forward primer) and RRG726 (tuf-Reverse primer) were designed based on 
the E. chaffensis, Arkansas whole genome sequence information obtained from Genbank 
(accession CP000236). The primers were obtained from Intergrated DNA technologies 
(Coralville, Iowa). These primers and E. chaffeensis genomic DNA were used to amplify 
‘tuf’ promoter region. Details of the PCR experiment were described below. 
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                                                 PCR reaction mixture 
2 ml HiFi PCR buffer (10 X) 
0.5 μl d NTP (10 mM) 
1 μl MgSO4 (50 mM) 
0.5 μl RRG 725 (10 μM)  
0.5 μl RRG 726 (10 μM) 
0.2 μl HiFi polymerase  
1 μl E. chaffeensis (7000) diluted  
14.3 μl Nuclease free water  
20 μl Total volume 
 
                                                    Temperature cycles 
Initial denaturation 94℃ for 2 min 
40 cycles  
Denaturation 94℃ for 30 sec 
Annealing 51℃ for 30 sec 
Extension 68℃ for 40 sec 
Final extension 68℃ for 10 min 
Soak 4℃ 
 
Predicted size PCR products (0.37 kb) were confirmed after resolving on a 0.9% agarose 
gel. Subsequently, two μl of the PCR product was used to ligate into the linear pBlue 
TOPO vector and recombinant plasmids containing the inserts were selected by following 
protocols outlined by the manufacturer (Invitrogen, CA).  
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4.2 Evaluation of tuf promoter activity by β-galactosidase assay 
β-galactosidase assay was performed by following instruction manual of β-galactosidase 
assay kit (Agilent Technologies, CA). Breifly, E. coli transformants containing the 
recombinant plasmids (pBlue-TOPO-tuf) were cultured overnight in 3 ml LB medium 
containing 50 µg/ml ampicillin, and centrifuge at 250 g for 5 min to remove the growth 
medium. One ml 1 X phoshate buffered saline (PBS) was added into each tube and 
centrifuged at 250 g for 5 min. The pellet was resuspended in 100 µl 1 X lysis buffer, and 
the sample was frozen on dry ice and thawed in a 37℃ water bath to promote bacteria 
lysis. This step of freezing and thawing was repeated twice. Then, the sample was 
centrifuged at 12000 g for 5 min in 4℃, and the supernatant was transferred into a 
microtiter plate. Samples were diluted at 1:100 and 10 μl of each was transferred into the 
wells containing 50 µl 1 X cleavage buffer with β-mercaptoethanol and 17 µl o-
Nitrophenyl-β-D-galactosidase (ONPG.). The plates were incubated in 37℃ for 30 min. 
The reaction was stopped by adding 125 µl stop buffer. The absorbance at 420 nM and 
the specific activity of tuf promoter (as assessed by the production of β-galactosidase per 
milligram of protein) were measured. 
N moles ONPG hydrolyzed = (OD420) (1.92 x 105 nl) / (4500 nl/ nmole-cm) (1cm) 
Specific activity = n moles ONPG hydrolyzed / mg/ protein 
 
5  Construction of pACD4K-C-gene 14/gene19/gene 126-tuf vector 
PBlue-TOPO-tuf and pACD4K-C-gene 14/gene 19/gene 126 were digested with Hind III, 
the desired fragments were isolated, phenol purified  and then ligated using T4 DNA 
ligase at 4℃ overnight. One µl of the ligation mixture was transformed into XL1-Blue 
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strain of E. coli chemically prepared competent cells by heat shock method as described 
above. Transformed cultures were plated onto LB plate containing chloramphenicol (25 
µg/ml) and incubated at 37℃ overnight. The colonies were screened for the insertion and 
correct orientation by plasmid DNA isolation, followed by Afl II and Hind III digestion 
and by sequence analysis. Methods for restriction enzyme digestion, ligation, and cloning 
and sequence analysis were similar to the methods previously described in this chapter. 
The constructs with the correct inserts and orientations were saved in -80℃ for future use. 
 
6  Construction of pACD4K-C-gene 14/19/126-tuf-rpsl-CAT 
The pACD4K-C-gene14/19/126-tuf plasmids were used to insert antibiotic cassette, 
chloramphenicol acetyltransferase (CAT) during expression using a transcrpitionally 
active E. chaffeensis promoter, rpsl. The DNA segment of rpsl-CAT was already prepared 
and is available in our laboratory as a recombinant plasmid. Primers were designed to 
amplify rpsl-CAT DNA segment. Both the primers included a MluI site at the 5’ ends to 
facilitate cloning into Targetron constructs. PCR products with MluI digested fragment 
were prepared and used for ligation with MluI digested plasmids of pACD4K-C-
gene14/19/126-tuf, T4 DNA ligations were performed as described previously. One µl of 
the ligation mixture was transformed into XL1-Blue chemical competent cells. The 
positive clones were screened and rpsl-CAT insert containing plasmids were verified by 
MluI digestion of plasmid DNA. The presence of inserts was also confirmed by plasmid 
DNA sequence analysis. The final constructs were used for preparing large quantity of 
plasmid DNAs by using Qiagen plasmid DNA maxi kit (Qiagen Inc. CA) and saved at -
80℃ for future use. 
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 7  Evaluating the transcription from Group II intron in Escherichia coli 
7.1 Performing RNA isolation from E. coli 
PACD4K-C-gene14/19/126-tuf-rpsl-CAT plasmids culturing E. coli cultures were grown 
in 5 ml of LB media containing chlorephenicol (25 µg/ ml) for almost 14 h at 37℃. Total 
RNA from the cultures were isolated using Tri-reagent method (Sigma Chemical 
Corporation, St. Louis, MO).  Briefly, 1.5 ml of culture was harvested by centrifuging at 
12,000 g for 5 min at 4℃.  To the cell pellet, 1ml of tri-reagent was added and vortexed 
to mix.  The lysates were incubated at room temperature for 5 min.  Two hundred μl of 
chloroform was added to the cell suspension, mixed by vortexing and incubated at room 
temperature for 10 min.  Subsequently, the samples were centrifuged at 12,000 x g for 15 
min at 4℃.  The top aqueous layer containing RNA was transferred into a clean micro 
centrifuge tube, mixed with 0.5 ml of cold isopropanol (-20℃) and incubated at room 
temperature for 10 min. The contents are centrifuged at 12,000 g for 15 min at 4℃. The 
RNA pellet recovered was rinsed with 70% ethanol and then resuspended in 100 μl of 
nuclease free water.  To prevent the degradation of RNA, 40 µl of RNase inhibitor 
(Ambion Corporation, Austin, TX) was added and stored at -80℃ until use.  
 
7.2 RNA analysis  
The total RNA was treated with RQ1 RNase-free DNase enzyme. Gel rig including 
combs and gloves were treated by washing with DEPC treated H20. Agarose gel was 
made by mixing 0.6 g agarose in 28.8 ml water and microwaving for 30 sec. When it 
cooled down to 60℃, 8 ml of 36% formaldehyal and 4 ml of 10 X MOPS were added 
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into agarose gel. RNA samples were prepared by adding 10 µl formaldehyde loading dye, 
heating at 65 ℃ for 15 min and chilling on ice. RNA running buffer was prepared by 
adding 25 µl of 10 X MOPS into 225 µl of DEPC. All of the samples were loaded onto 
gel and run at 70 V for 1 h.  
 
7.3 RT-PCR analysis 
Two PCR and one RT-PCR were performed using 10 µM Primers (IBS and EBS1d). RT-
PCR for extracted RNA was designed to confirm the transcription of pACD4K-C-gene 
14/19/126-tuf -rpsl-CAT in E. coli. PCR for extracted RNA was designed as the negative 
control for the transcription, and PCR for plasmid DNA was designed as the positive 
control for the transcription. In addition, another negative control was set up by using 
RNase free water as the templates. The RT-PCR reaction was performed as follows: 
reverse transcription at 48℃ for 1 h; initiation at 94℃ for 30 sec; and 25 cycles for 
(denaturation at 94℃ for 15 sec, annealing at 55℃ for 30 sec and extension at 72℃ for 
30 sec); then elongation at 72℃ for 2 min, and final soaking at 4℃. 
 
8  Preparation of Ehrlichia chaffeenis for transformation experiments  
8.1 In vitro cultivation of E. chaffeensis:  
The Arkansas isolate of E. chaffeensis was cultivated in vitro in the canine macrophage 
cell line DH82 at 37°C, by following the protocols established before (Chen et al., 1994; 
Munderloh et al., 1999).   
 
8.2 Purification of E. chaffeensis:   
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E. chaffeensis infected macrophage cultures were harvested when the infectivity reached 
to 80-90 % in nearly 100% confluent flasks.  Infection was assessed by microscopic 
examination of polychromatic stained cytospin slides.  About 25 ml of infected culture 
was collected into a 50 ml sterile falcon tube and centrifuged at 15,000 g for 15 min.  The 
supernatant was discarded and the pellet is resuspended in 10 ml of 0.25 M ice cold 
sucrose solution.  The cells were lysed by adding 1 mm diameter glass beads and 
vortexing twice for 30 sec.  The lysed cell suspension was transferred to a new sterile 
tube free of glass beads and centrifuged at 100 g for 10 min. The supernatant was 
carefully collected and transferred to a new tube and centrifuged at 15,000 g for 15 min 
to collect cell-free Ehrlichia organism. At the end of centrifugation, supernatant was 
discarded and the cell-free bacteria pellet was resuspended in 10 ml of 0.25 M ice cold 
sucrose.  The centrifugation step was repeated one more time and the final E. chaffeensis 
organism pellet was resuspended in 0.6-1 ml of 0.25 M sucrose solution. 
 
8.3 Preparation of plasmid DNA for electroporation 
Grow 100 ml of pACD4K-C gene 14/19/126-tuf -rpsl-CAT plasmids containing E. coli in 
LB media with chloramphenicol (25 µg/ml) for about 16 h. The cultures were used to 
isolate plasmid DNA by following the protocols outlined by EndoFree Plasmid 
Purification Kit (QIANGEN, CA). Briefly, the culture was centrifuged at 6,000 g for 15 
min at 4℃, and then the supernatant was discarded. The pellet was resuspended in 10 ml 
buffer P1 (QIANGEN, CA), and mixed thoroughly with 10 ml buffer P2 (QIANGEN, 
CA), followed by incubating at room temperature 24℃ for 5 min. During the incubation, 
the QIAfilter Cartridge was prepared (screw the cap onto the outlet nozzle of the 
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QIAfilter Maxi Catridge and place the QIAfilter Cartridge in a convenient tube). Ten ml 
chilled buffer P3 (QIANGEN, CA) was added to the lysate, and mixed immediately and 
thoroughly by vigorously inverting for 6 times (do not incubate the lysate on ice). The 
lysate was poured into the barrel of the QIAfilter Cartridge, and incubated at room 
temperature for 10 min. The cap from the QIAfilter Catridge outlet nozzle was removed. 
The plunger was gently inserted into the QIAfilter Maxi Cartridge and the cell lysate was 
filtered into a 50 ml tube. Two point five ml buffer ER (QIANGEN, CA) was added to 
the filtered lysate, mixed by inverting the tube approximately 10 times, and incubated on 
ice for 30 min. A QIAGEN-tip 500 was equilibrated by applying 10 ml buffer QBT 
(QIANGEN, CA), and allowing the column empty by gravity flow. The filtered lysate 
was applied to the QIAGEN-tip. The QIAGEN-tip was washed with 30 ml buffer QC 
(QIANGEN, CA) for 2 times. Plasmid DNA was eluted with 15 ml buffer QN 
(QIANGEN, CA) and precipitated by adding 10.5 ml room-temperature isopropanol, 
followed by mixing and centrifuging immediately at 15,000 g for 30 min at 4℃. The 
supernatant was carefully decanted. DNA pellet was washed with 5 ml of endotoxin-free 
room-temperature 70% ethanol (40 ml of 96-100% ethanol was added to the endotoxin-
free water supplied with the kit) and centrifuged at 15,000 g for 10 min. The supernatant 
was carefully decanted without disturbing the pellet. The pellet was air-dried for 10 min, 
and the DNA was redissolved in 100 µl endotoxin-free buffer TE (QIANGEN, CA). The 
purified plasmid was stored at -80℃ for later use. 
 
9  Transformation with E. chaffeensis in DH 82 macrophage cells 
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E. chaffeensis cultures were grown in macrophage cell line, DH 82, and when infection 
reached to > 90%, cultures were harvested by spinning at 15, 000 g for 15 min at 4℃. To 
the pellet, 10 ml of ice-cold 0.25 M sucrose solution was added and vortexed to 
resuspend the culture. The host cells were broken by passing through 27.5 gauge bended 
needles for 4 times, and spinning at 200 g for 10 min at 4℃ to pellet the cell debris. The 
supernatant was filtered through 2.7 µm filter and spun at 15,000 g for 15 min at 4℃ to 
collect the cell free bacteria. The pellet was washed twice with ice cold sucrose solution 
(0.25 M) and the final pellet was resuspended in 0.6-1 ml of 0.25 M ice-cold sucrose. The 
final sucrose solution varied depending on the bacteria volume and 100 µl each of the 
purified E. chaffeensis suspension was used for transformation expressions. One µl 
plasmid DNA (20 µg/ml) of pACD4K-C-gene 14/19/126-tuf-rpsl-CAT and 100 µl of cell 
free bacteria was mixed in an electroporate cuvette for use in electroporation. The 
electroporation was performed twice at 1800 V. To serve as a control, 100 µl of cell-free 
bacteria were also electroporated by giving double shock at 1800 V. The electroporated 
cells were transferred into T 25 cm2 flask of DH82 cells having 80% confluency (5 ml 
culture volume). The electroporate cuvettes were washed with 400 µl of MEM medium, 
and then transferred the contents to the respective culture flask. The culture flasks were 
incubated at 37℃ for overnight. Fraction of cultures from each flask (1.5 ml each) were 
harvested at different times post transformation (6 h, 12 h, 24 h, 48 h and 6 days) for use 
in DNA isolation and analysis. To the remaining culture, media is replaced every three or 
four days and E. chaffeensis infection was monitored for up to two months. The culture 
flasks with 2 μg/ml chloramphenicol were starting from the day six following 
transformation.  
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10  Methods for monitoring transformants   
Total genomic DNAs of recovered cultures were isolated using QIAamp DNA Mini Kit 
(QIAGEN, CA). PCR analysis was performed by using primers spanning the expected 
insertion regions, one targeted to group II intron mutated genes and the other targeted to 
E. chaffeensis genome. The presence of genetically modified E. chaffeensis was also 
assessed by microscopic analyzing polychromatic stained culture slides and evaluating 
the growth or lack of growth of the mutants.  Any culture that appeared to be positive was 
further evaluated by molecular techniques.   
 
The PCR products were then resolved on a 0.9% agarose gel by subjecting to 40 V for 6 h 
and the resolved DNA was transferred to a nylon membrane. The prehybridization 
solution stock was prepared at final concentration of (6 X SSC, 10 mm pH 6.8 NaPO4 
buffer, 1 mm EDTA pH 8.0, 10 X Denhard’s, 100 µg/ml ssDNA, and 0.5% SDS). The 
membrane was prehybridized for 2 h at 68℃. The 32P-labeled DNA probes for the group 
II intron was synthesized by using Primer-It II Random primer labeling kit (Stratagene, 
CA). After 14 h of hybridization at 68 ℃, the membrane was washed once with 6 X SSC, 
0.1% SDS followed by one wash at 2 X SSC, 0.1 % SDS, one wash at 1 X SSC, 0.1% 
SDS, and a final wash at 0.1 X SSC, 0.1% SDS.  The nylon membrane was then exposed 
to an X-ray film at -70℃ by using an intensifying screen.  The X-ray film was developed 
and presence of group II intron segments within E. chaffeensis genome was assessed 
from the autoradiograph. 
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ABSTRACT 
 
 
 
Ehrlichia chaffeensis is an emerging tick-borne rickettsial pathogen that causes infection 
in people and several vertebrate animals.  One of the striking features of E. chaffeensis 
infection is the prolonged persistence in its vertebrate and tick hosts. The mechanisms of 
persistent infection and the reasons for the host immune system failure to clear the 
infection are not well understood. One hypothesis is that differential gene expression 
serves as an important adaptive mechanism used by E. chaffeensis in support of its 
continued survival in both tick and vertebrate hosts. One way to test this hypothesis is by 
performing mutational analysis.  The methods for introducing mutations in this pathogen 
have not yet been documented and are challenging, possibly due to its obligate, 
intraphagosomal growth requirement. A novel gene mutation method, called ‘TargeTron 
Gene Knockout System’ that is based on the modified group II intron insertion strategy 
has been developed recently, are used to create mutations in a wide range of gram 
positive and gram negative bacterial organisms. The objective of this study is to create 
mutations in E. chaffeensis using the TargeTron gene knockout system. Three E. 
chaffeensis genes: Ech_0126 (a transcriptionally silent gene), macrophage-specific 
expressed gene (p28-Omp 19) and tick cell-specific expressed gene (p28-Omp 14) were 
evaluated for mutational analysis.  Group II intron was modified for retargeting to these 
genes and its expression in E. chaffeensis is accomplished using the pathogen-specific 
high-expressing gene promoter (tuf) inserted upstream to the transcription starting site. In 
addition, a chloramphenicol acetyltransferase gene with E. chaffeensis rpsl promoter 
(another transcriptionally active, high expression gene promoter) was introduced for use 
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as an antibiotic selection marker.  The constructs were evaluated by transforming into E. 
chaffeensis. Transformants with mutations introduced in two of the three genes 
(Ech_0126 and p28-Omp 19) were identified by PCR and Southern blot methods for up 
to 48 h. This is the first report which demonstrates the creation of mutations in E. 
chaffeensis. Establishment of stable transformants, however, requires additional 
modifications to the constructs. The outcomes of this study will have important 
implications in defining the pathogenesis of E. chaffeensis and other closely related 
bacteria to assess the functional significance of host specific differential expression in the 
organisms in tick and vertebrate hosts.   
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Introduction 
E. chaffeensis, an intracellular tick-transmitted rickettsial, is the agent of an infectious 
disease termed human monocytic ehrlichiosis (HME). Despite the increased incidence of 
HME in the USA (Paddock et al., 2003; McNabb et al., 2008), efficient methods to 
control the illness remain to be established.  
Recent studies demonstrate that the pathogen gene expression is significantly different 
when it replicates in tick cell compared to its growth in vertebrate macrophages (Ohusi et 
al., 1998; Unver et al., 2002; Long et al., 2002; Singu et al., 2005; Seo et al., 2008). 
Studies which evaluated host immune response in the mouse model also suggested that 
the tick cell-derived E. chaffeensis persist pathogen (Ganta et al., 2002; Ganta et al., 2004; 
Ganta et al., 2007). The delayed clearance in the murine host is also associated with 
altered host immune response (Ganta et al., 2002; Ganta et al., 2004; Ganta et al., 2007). 
The evaluation of differential expressed E. chaffeensis proteins will be useful in creating 
mutation.  
 
‘TargeTron Gene Knockout System’ that is based on the modified group II intron 
insertion strategy has been utilized for creating mutations in several gram negative and 
gram positive bacteria. In this study, we evaluated the feasibility of creating mutations in 
E. chaffeensis using Group II intron based strategy. Three E. chaffeensis genes were 
assessed and the results from this study and their implication were discussed. 
 
Result 
1 Construction of plasmids for retargeting group II intron for inserting mutations in 
E. chaffeensis genome 
1.1 PCR for intron re-targeting in genes of E. chaffeensis: 
Genomic sequences of E. chaffeensis genes, Ech_1136 (p28-Omp gene 14), Ech_1143 
(p28-Omp gene 19) and Ech_0126 were uploaded to Sigma-Aldrich company website 
( www.sigma-aldrich.com/targetron), and three primers (IBS, EBS-1d, EBS-2) for each 
gene were designed and synthesized commercially for each gene-specific retargeting 
(Table 3.1) (Gene-specific retargeting regions were identified in italics and bold text in 
the primers). The PCR amplification was performed using group II intron as template 
using each gene-specific retargeted primer. Retargeted PCR products of 0.35 kb for each 
gene were identified in the ethidium bromide stained agarose gel (Figure 3.1). 
 
 
 
 
 
 
 
 
Figure 3.1  PCR for intron retargeting in gene 14, gene 19 and gene 126 of E. chaffeensis. Lanes 1, 2, 
3 are Ech_1136 (p28-Omp gene 14), Ech_1143 (p28-Omp gene 19) and Ech_0126, respectively.
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1.2   Ligation and recombination plasmid construction 
1.2.1 Restriction enzyme digestion  
To engineer the retargeted PCR products into group II intron cassette, PCR products and 
pACD4K-C plasmids (Sigma, St. Louis, MO) were digested separately with Hind III and 
BsrG I restriction enzymes. The plasmid segment of 6.9 kb containing the active group II 
intron fragment, but lacking the lacZα segment of 0.76 kb was isolated and ligated with 
RE.digested retargeted PCR products for genes Ech_1136, Ech_1143 and Ech_0126 
using T4 DNA ligase. The ligated products were transformed into E.coli strain, XL1 Blue, 
plated on agar plates containing chloramphenicol (25 µg/ml), white colonies were picked 
and screened for the presence of the retargeted inserts. 
 
 
 
 
 
 
 
 
           
Figure 3.2   Double digestion of the retargeted PCR products and pACD4K-C plasmids with Hind III 
and BsrG I.  Lanes 1 and 2 are pACD4K-C plasmids; lanes 3, 4, and 5 are retargeted PCR product for 
Ech_1136, Ech_1143, and Ech_0126; M represents marker in base pairs. 
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1.22 Confirmation of constructed plasmids pACD4K-C-gene 14/19/126 by restriction 
enzyme digestion. The plasmid DNAs were isolated from the liquid cultures of 
transformants by boiling preparation method and assessed for the presence of specific 
inserts size (Figure 3.3). Fragments of about 350 bp Hind III and BsrG I digested 
products were identified in several clones. 
 
 
 
 
 
 
 
         
Figure 3.3   Double digestion of constructed plasmids pACD4K-C- gene 14/ 19/126 with Hind III and 
BsrG I (the arrow indicates the 350 bp size fragments). 
 
1.3   Verification of modified intron 
Three clones from each gene were randomly selected and the sequence modifications in 
pACD4K-C-gene 14/gene 19/gene 126 plasmids were determined by CEQ-8000 gene 
analytic system for DNA sequencing. These modified plasmid containing E. coli cultures 
were stored in -80℃ as glycerol stocks for subsequent use in isolating plasmid DNAs.  
 
1.4  Insertion of E. chaffeensis promoter  
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To drive the expression of modified group II introns in E. chaffeensis, we identified a 
strong transcriptionally active E. chaffeensis gene promoter, tuf. This promoter activity 
was primarily determined by our group (Unpublished data). To clone the promoter region 
of tuf, two primers were designed (RRG 725 and RRG 726) (Table 3.1) and used in a 
PCR to amplify from E. chaffeensis genome. To facilitate cloning upstream to modified 
group II introns in pACD4K-C plasmids, Hind III restriction sites sequence were 
engineered in the primers. PCR products were evaluated in 0.9 % agarose gel by 
subjecting to electrophoresis at 120 V for 1 h. Predicted fragment of 374 bp was detected 
in the gel under UV light (Figure 3.4). 
 
 
 
 
 
 
 
 
Figure 3.4   PCR for tuf promoter. 
 
E. chaffeensis tuf promoter PCR products were cloned into pBlue-TOPO vector by 
following the protocol described by Invitrogen pBlue-TOPO TA Expression Kit 
(Invitrogen, CA). The pBlue-TOPO plasmid contains a promoterless LacZ gene placed 
down stream to multiple cloning site regions. If the promoter inserted (such as the tuf) is 
active, β-galactosidase proteins will be made in E.coli cultures containing the 
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recombinant plasmid. Tuf promoter inserted pBlue-TOPO plasmids were assessed for 
transcriptional activity by β-galactosidase assay. The results showed that the 
transcriptional activities of plasmids containing tuf promoter are 11.58 and 15.3 times 
higher (Figure 3.5; lanes 2 and 3) than the control (pBlue-TOPO vector without inserts, 
lane 1), suggesting that tuf promoter of E. chaffeensis is a strong promoter during the 
expression of β-galactosidase in E. coli. 
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Figure 3.5   β-galactosidase activity of tuf promoter.  Lane 1, lysates of E.coli containing pBlue-TOPO 
plasmid without inserts; lanes 2 and 3 contained E. coli lysates prepared from two randomly selected 
clones of pBlue-TOPO vector with tuf promoter. 
 
1.4.1 Restriction enzyme digestion  
The plasmids pACD4K-C-gene 14/19/126 and a tuf promoter plasmid of pBlue-TOPO 
were digested by Hind III and digested products were isolated and analyzed in 0.9 % 
agarose gel to verify the recovery of DNA fragments. Fragments of 7,677 bp of 
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pACD4K-C- gene 14/19/126 linear DNA and 374 bp of tuf promoter were isolated and 
observed under UV light (Figure 3.6).   
 
 
 
 
 
 
 
 
Figure 3.6   Hind III digestion of plasmids pACD4K-gene 14/19/126 and tuf promoter. Lanes 1, 2, 3, 
and 4 are plasmid pACD4K- Ech_1136, plasmid pACD4K- Ech_1143, plasmid pACD4K- Ech_0126 
and tuf promoter, respectively. 
 
1.4.2   Cloning of tuf promtor in front of group II introns in pACD4K-C plasmids 
Purified Hind III digested pACD4K-C plasmid segments with retargeted group II introns 
for E. chaffeensis genes for Ech_1136, Ech_1143, and Ech_0126, and tuf promoter DNA 
were ligated, cloned into E. coli (TOP 10 strain), and plasmids with correct orientation 
were selected by following standard molecular cloning methods. The constructed 
plasmids pACD4K-C-tuf were picked from bacteria culture plates containing 
chlorephenicol (25 µg/ml) and cultured overnight in 3 ml of LB plus chlorephenicol (25 
µg/ml). The plasmid DNAs from liquid cultures were extracted by boiling preparation 
method and digested with Afl II and EcoRV to confirm the orientation of tuf promoter 
inserts.  For gene 19 and gene 126, fragments of 7,219 bp plus 814 bp should be 
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observable in the plasmids with forward insertion (and a 18 bp fragment should also be 
released); and fragments of 6849 bp plus 814 bp and 388 bp should be observable in the 
plasmids with reverse insertion. For gene 14, fragments of 7219 bp plus 832 bp should be 
observable in the plasmids with forward insertion; and fragments of 6849 bp plus 1202 
bp should be observable in the plasmids with reverse insertion. The result indicate that 
both gene 14 plasmids are in forward orientation; one each of the gene 19 plasmids are in 
forward and reverse orientation (lanes 3 and 4); and one of the gene 126 plasmids has 
forward orientation (lane 6) and the other does not have any inserts (lane 5).  
 
 
 
 
 
 
 
 
Figure 3.7  Confirmation of pACD4K-C-gene 14/19/126-tuf.  Lanes 1 and 2, Ech_1136; lanes 3 and 4, 
Ech_1143; and lanes 5 and 6, Ech_0126. 
 
The final constructs of pACD4K-C-gene 14/19/126-tuf were verified by sequencing 
analysis in CEQ-8000 gene analytic system. The verified constructs containing E. coli 
cultures in TOP 10 strain were stored as glycerol stocks at -80℃ for long term use.  
 
1.5   Insertion of rpsl-CAT 
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1.5.1   PCR for rpsl-CAT 
Rpsl-CAT fragment was amplified by PCR, using previously prepared plasmid construct 
containing the E .chaffeensis rpsl promoter and CAT gene coding sequence (available in 
our laboratory). After PCR reaction, 3 µl of PCR products were analyzed in an agarose 
gel to identify predicted fragment of 948 bp. 
 
 
 
 
 
 
 
Figure 3.8   PCR for rpsl-CAT. 
 
1.5.2 Restriction enzyme digestion of the PCR products of rpsl-CAT and the plasmids of 
pACD4K-C-gene 14/19/126-tuf. PACD4K-C constructs contain a kanamycin gene 
cassette downstream to group II intron and within the intron encoding protein coding 
region. This cassette can be replaced with an alternate antibiotic selection marker, such as 
chloramphenicol acetyltransferase (CAT), as it is present between two MluI restriction 
enzyme sites as a 1.37 kb insert. The PCR products of rpsl-CAT (0.95 kb) were also 
engineered to contain MluI sites at both ends of the segment. The PCR products of rpsl-
CAT and the plasmids of pACD4K-C-gene 14/19/126-tuf were digested by MluI. 
Digested products were resolved in an agarose gel to identify predicted fragments (6.67 
kb and 1.37 kb from plasmids and 0.95 kb for rpsl-CAT (Figure 3.9)). 
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Figure 3.9     Double digestion with MluI.  Lanes 1, 2, 3 and 4 are digested PCR products of rpsl-CAT, 
the digested plasmid of pACD4K-C-gene 14, the digested plasmid of pACD4K-C-gene 19, and the 
digested plasmid of pACD4K-C-gene 126, respectively. 
 
The MluI digested fragment of 6.67 kb for each of the three plasmid constructs for 
Ech_1136, Ech_1143, and Ech_0126 genes and 0.95 kb of rpsl-CAT were isolated and 
used in ligation and cloning experiments in E. coli (TOPO 10 strain) to recover plasmids 
containing the rpsl-CAT inserts (Figure 3.10). The constructed plasmids pACD4K-C-
gene 14/19/126-tuf-rpsl-CAT were prepared by boiling preparation method. The presence 
of rpsl-CAT inserts of 0.95 kb fragments were confirmed by digesting with MluI enzyme. 
The presence of correct sequence in the rpsl-CAT inserts was further confirmed by 
sequence analysis. The final constructs were stored in -80℃ for later use. 
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Figure 3.10   Confirmation of pACD4K-C-gene 14/19/126-tuf-rpsl-CAT.  Lanes 1, 2, 3 are the plasmid 
contructs for Ech_1136, Ech_1143, and Ech_0126 genes, respectively. 
 
2. Evaluating the transcription from Group II intron in Escherichia coli 
PACD4K-C-gene 14/19/126-tuf -rpsl-CAT plasmids containing E. coli cultures were 
grown in 5 ml of LB media containing chlorephenicol (25 µg/ ml) for almost 14 h at 37℃. 
Total RNA from the cultures was isolated using Tri-reagent method (Sigma Chemical 
Corporation, St. Louis, MO) (Figure 3.11).  The total RNA was treated with RQ1 Rnase-
free Dnase enzyme. RNAs were analyzed for the presence of transcripts of group II 
intron driven by E. chaffeensis tuf promoter. Specifically, a primer set targeted to 
retargeted segments (Forward primers are IBS and reverse primers are EBS1d) was used 
to assess the expression (Figure 3.12). No products were detected when no template was 
used or when RNA template was used in a PCR for the RNA from retargeted plasmid 
containing E. coli of gene 14 and gene 19. Weak positive product was observed in PCR 
product of gene 126. When RNA was used in RT-PCR, all three RNAs yielded the 
predicted amplicons. For gene 126 construct RNA, the amplified product for RNA is 
significantly more than that observed in PCR. This suggests that the presence of positive 
PCR product in gene 126 construct RNA in the absence of reverse transcriptase may be 
due to residual plasmid DNA contamination. Together, these results demonstrate that the 
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group II intron constructs prepared for genes 14, 19, and 126 are functional in making 
transcripts. 
 
               
 
 
 
               
Figure 3.11   RNA gel of plasmids pACD4K-C-gene 14/19/126-tuf -rpsl-CAT.  Lanes 1, 2, 3, 4, 5, 6 
and 7 are the total RNA isolated using Tri-reagent methods. 
  
  
 
 
 
 
 
 
Figure 3.12  RT-PCR, PCR for extracted RNA and PCR for plasmid DNA.  Lanes 1, 5, and 9 are 
negative controls using Rnase free water as the template; lanes 2, 6, and 10 are PCR for plasmid DNA; 
lanes 3, 7 and 11 are PCR for extracted RNA; lanes 4, 8 and 12 are RT-PCR for extracted RNA. 
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3 Transformation and mutation analysis  
The modified Targetron plasmids for use in creating mutations in E. chaffeensis genes, 
Ech_1136, Ech_1143, and Ech_0126 were used in transformation experiments. Typically, 
20 µg of purified plasmid DNA was electroporated into purified E. chaffeensis organism 
recovered from about 10 ml of 80-90% infected macrophage cultures representing ~80% 
confluency. The experiments of transformation were performed three times. E. 
chaffeensis was subjected to electroporation with the plasmids pACD4K-C-gene 
14/19/126-tuf-rpsl-CAT by double shock at 1800 V.  The experiment also included a 
control electroporation reaction that contained only E. chaffeensis organism and a second 
control that contains E. chaffeensis organism that were not subjected to electroporation. 
Electroporated and non electroporated E. chaffeensis organism were cultured in DH82 
macrophage cells and harvested at different times. In the first experiment, the cells were 
harvested at 6 h, 12 h and 24 h; in the second and third experiment, the harvested cultures 
included at 6 h, 24 h, 48 h and 6 days. The harvested cultures were used to recover total 
genomic DNA for assessing the integration of group II introns into E. chaffeensis genome 
at the predicted locations of Ech_1136, Ech_1143, and Ech_0126 genes (describled 
below). After harvesting the last batch of culture for DNA isolation, chloramphenicol was 
added to the culture media at a concentration of 2 µg/ml. Infection in DH82 cultures were 
monitored for up to two months by microscopy analysis. To date, no positive infection 
was found from all three transformation experiments. For further testing the insertion, 
PCR and Southern blot were performed. 
 
3.1 Detection of insertions assayed by PCR methods  
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Two types of PCRs were performed to assess the integration of group II introns into E. 
chaffeensis genome. In the first set of PCRs, primers were designed to bind to the region 
upstream and downstream to integration site (these primers were expected to yield 
positive PCR products independent of the insertions). In the second set of PCRs, one 
primer is targeted E. chaffeensis genome either upstream or downstream to the insertion 
sites. The second primer of the second set was targeted to group II intron segment. The 
strategy and expected amplified fragments were described in Figure 3.13. To assess the 
mutations, the PCR products were analyzed in a 0.9 % agarose gel as well as Southern 
blot analysis after transferring to a nylon membrane and hybridization with group III 
intron specific 32P-labeled DNA probes.  
 
 
 
 
 
 
 
 
                                  
 
                                 
  
 
                                  
 
                            
 
 
 
 
 
 
 
 
                                       Figure 3.13   PCR strategies for detecting mutants. 
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As outlined in the cartoon of Figure 3.13, predicted fragments from various PCR 
samples were analyzed for agarose gels or in the Southern blot results from PCR 
DNA hybridized with group II intron probe. Figure 3.14 has the agarose gel data for 
first experiment. In non-transformants and transformants for gene 14, we expected to 
see 0.86 kb and 2.92 kb amplicons, respectively, when PCR I is performed. In the gel, 
we did detect 0.86 kb, but not the 2.92 kb (Lanes 2, 4 and 6 of Figure 3.14). Predicted 
0.82 kb fragment for PCR IIa was also not visible in the analyzed PCR products of 
gene 14 transformants (Lanes 1, 3, and 5 of Figure 3.14). Similar experiments for 
gene 19 yielded predicted fragments for PCR I (0.24 kb for gene 19; lanes 8, 10 and 
12 of Figure 3.14) and for gene 126 as well (2.7 kb; lanes 14, 16 and 18 of Figure 
3.14). As observed from results of gene 14, expected amplicons for transformants for 
genes 19 and 126 (2.3 kb and 4.7 kb, respectively) were also not clearly visible. The 
analysis was also complicated with the presence of multiple non-specific amplified 
DNA fragments observed in the agarose gel. PCR IIa strategy should yield positive 
bands only if the genomic DNA included insertion mutations (for gene 14, 0.82 kb; 
for gene 19, 0.39 kb and for gene 126, 2.8 kb). The predicted fragments were 
undetectable for gene 14 PCR IIa products (Lanes 1, 3, and 5 of Figure 3.14). 
However, we do detect minor predicted bands for gene 19 and 126 PCR IIa amplicons. 
In addition, we observed multiple non-specific amplicons in the lanes representing 
PCR IIa of genes 19 and 126 (Lanes 7, 9 and 11 of Figure 3.14 for gene 19 and lanes 
13, 15 and 17 of Figure 3.14 for gene 126).  
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Figure 3.14   Experiment 1, PCR assay for detecting insertion.  Lanes 1, 2, 3, 4, 5 and 6 are gene 14; 
lanes 8, 9, 10, 11 and 12 are gene 19; and lanes 13, 14, 15, 16, 17 and 18 are gene 126; Lanes 1, 3, 5, 7, 
9, 11, 13, 15, 17 are PCR IIa, and Lanes 2, 4, 6, 8, 10, 12, 14, 16, 18 are PCR I; Lanes 1, 2, 7, 8, 13, 14 
are the electroporated cells harvested after 6 h; lanes 3, 4, 9, 10, 15, 16 are the electroporated cells 
harvested after 12 h; lanes 5, 6, 11, 12, 17, 18 are the electroporated cells harvested after 24 h. 
 
 
 
 
 
 
 
 
Figure 3.15   Experiment 2, PCR assay for detecting insertion.  Gene 14, gene 19 and gene 126 all 
have equal 6 lanes. For each of the six lanes, the templates for PCR assay are: from right to left, post 6 
h harvested culture, post 24 h harvested culture, post 48 h harvested culture, post 6 days harvested 
culture, E. chaffeensis genome and nuclease free water. 
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Figure 3.16   Experiment 3, PCR assay for detecting insertion.  Lanes 1, 2, 3, 4, 5 and 6 are PCR IIb 
for gene 19; lanes 7, 8, 9, 10, 11 and 12 are PCR IIa for gene 126; lanes 13, 14, 15, 16, 17 and 18 are 
PCR IIa for gene 19; lanes 19, 20, 21, 22, 23 and 24 are PCR I for gene 126; lanes 25, 26, 27, 28, 29 
and 30 are PCR I for gene 19; and lanes 31, 32, 33, 34, 35 and 36 are PCR IIb for gene 126. For each 
of the six lanes, the templates for PCR assay are: from right to left, post 6 h harvested culture, post 24 
h harvested culture, post 48 h harvested culture, post 6 days harvested culture, E. chaffeensis genome 
and nuclease free water. 
 
3.2 Southern blot analysis 
To further evaluate the insertion mutations, PCR DNAs resolved in the agarose gel were 
transferred to a nylon membrane and assessed by Southern blot using group II intron 
specific 32P-labeled DNA probe. In the first experiment, predicted DNA amplicons in 
PCR IIa products were detected only for gene 19 and 126, and no detectable signals were 
observed for gene 14 (Figure 3.17). The signal intensity for gene 19 was the highest for 
12 h post-transformation and 6 h post-transformation for gene 126. For gene 126, we also 
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observed smaller size non-specific amplicons. The signal intensity decreased in the 
samples anayzed for 24 h of gene 19 and 12 h and 24 h for gene 126. In the experiment 2 
and 3, group II insertion strategy, using the modified Targetron plasmids for E. 
chaffeensis genes 14, 19 and 126, was repeated two additional times. In the second 
experiment (Figure 3.18), only PCR IIa strategy was followed to assess the presence of 
mutations in E. chaffeensis genome. Similar to the first experiment, agarose gel analysis 
had no detectable amplicons for gene 14 and multiple bands for gene 19 and 126 
transformants. The resolved DNAs were transferred to nylon membrane and hybridized 
with group II intron probe to see if we can identify predicted amplicons. Consistent with 
the first experiment, Southern blot data was negative for gene 14, and positive for genes 
19 and 126. Insertion-specific amplicons decreased for 6 h post-tranformation to 48 h 
post-transformation for gene 19 and undetectable in the DNA harvested after 6 days post-
transformation. Similar analysis for gene 126 yielded positive only for 6 h time point. In 
the third experiment, we performed PCRs using the strategy of I, IIa, and IIb (as outlined 
in Figure 3.13). In addition, using the amplicons from the PCRs, we perfomed nested 
PCRs (two pairs of PCR primers were used. The first pair of primers amplified the locus 
as seen in any PCR experiments, the second pair of primers bind within the first PCR 
product and produce a second PCR product that will be shorter than the first one.). The 
aim for this experiment is to see if we can reduce the non-specific amplicons and also to 
enhance the signal intensity of the amplified products. The analysis for this experiment 
was performed for 6 h, 24 h, 48 h and 6 d similar to the second experiment. 
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Figure 3.17   Experiment 1, Southern blot for detecting insertion.  6 h: Southern blot for post 6 h 
harvested culture; 12 h: Southern blot for post 12 h harvested culture; and 24 h: Southern blot for post 
24 h harvested culture. 
 
 
 
 
 
 
 
 
Figure 3.18   Southern blot for experiment 2.  6 h: Southern blot for post 6 h harvested culture; 24 h: 
Southern blot for post 24 h harvested culture; 48 h: Southern blot for post 48 h harvested culture; and 
6 D: Southern blot for post 6 days harvested culture. 
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Figure 3.19   Southern blot for experiment 3.  Lanes 1, 2, 3, 4 are 6 h, 24 h, 48 h and 6 d post 
transformation culture of gene 19 using PCR IIa; lanes 5 is 6 h post transformation culture of gene 126 
using PCR IIa. 
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Discussion 
E. chaffeensis is an emerging tick-borne pathogen responsible for an important disease in 
people, human monocyte ehrlichiosis (Dawson et., 1991; Lockhart et al., 1995).  The 
disease was first discovered in 1987 and subsequently reported in many parts of the USA 
and world (Bakken et al., 1996; Bakken et al., 1998; Dumler et al., 1998; Whitlock et al., 
2000; Standaert et al., 2000; Olano et al., 2003; Paddock et al., 2003; McNabb et al., 
2008). E. chaffeensis also causes infections in several other vertebrate hosts (Dugan et al., 
2000; Yabsley et al., 2004; Dugan et al., 2005; Yu et al., 2008).  Despite recent progress, 
the pathogensis and how the organism persists in vertebrate hosts and ticks still remain to 
be known.  
 
Recent studies demonstrate differential expression of E. chaffeensis proteins in a host cell 
specific manner (Ohusi et al., 1998; Unver et al., 2002; Long et al., 2002; Singu et al., 
2005; Seo et al., 2008). The protein expression differences are also shown to be 
influencing the host response and the pathogen persistence (Brelun et al., 1996; Cotter et 
al., 2000). In this study, we evaluated a method to create mutations in E. chaffeensis 
genome. Targetron mutagenesis system can be exploited to introduce mutations in 
virtually any bacterial organism (Yao et al., 2006; Cui et al., 2007; Heap et al., 2007; 
Rodrigurez et al., 2008). However, to adapt to a species, such as to E. chaffeensis, one 
needs to make several manipulations to the Targetron constructs prior to use in creating 
mutations in the organism. First, we needed to identify suitable regions to create 
mutations in the E. chaffeensis genome. Second, we had to adapt the group II intron 
expression system for E. chaffeensis using a constitutively expressing gene promoter of 
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this organism. Third, we were required to introduce an antibiotic selection marker 
cassette into the Targetron constructs. The antibiotic resistance protein expression also 
requires an E. chaffeensis promoter that is stably expressed. Once the constructs were 
prepared, appropriate conditions for introducing foreign DNA into E. chaffeensis and 
methods to recover viable cultures were also necessary. In this project, our efforts were 
focused to develop all the above described methods.  
 
We selected three genes of E. chaffeensis for creating mutations: 1) a gene which 
appeared to be transcriptionally silent (Ech_0126); 2): a gene predominantly expressing E. 
chaffeensis when it replicates in tick cells (Ech_1136; p28-Omp gene 14); and 3) a gene 
primarily expressed in the organism when grown in macrophages (Ech_1143; p28-Omp 
gene 19). The justification for selecting these genes are as follows: if a mutation is 
detrimental for E. chaffeensis, we may not be able to recover viable cultures following 
the introduction of such mutations. Therefore, we selected a transcriptally silent gene 
(Ech_0126) for one of the experiment. Assuming that this gene is not important for E. 
chaffeensis survival, we may be able to recover positive mutants if introduced in this gene. 
The choice of tick cell specific gene expression may allow the mutant E. chaffeensis to 
grow well in macrophage cultures, but may not allow its growth in tick cell cultures. 
Thus, we selected Ech_1136 for this type of mutations. This gene, also referred to as p28-
Omp 14 gene, is primarily expressed in the organism replicating in ticks cells or in 
infected ticks (Ganta et al., 2002; Ganta et al., 2004; Ganta et al., 2007). In the third 
selection, Ech_1143 was selected as it is abundantly expressed in macrophage cultures or 
infected vertebrate hosts (Ganta et al., 2002; Ganta et al., 2004; Ganta et al., 2007). This 
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gene is also expressed at low levels in tick cell-derived bacteria (Ganta et al., 2002; 
Ganta et al., 2004; Ganta et al., 2007). This gene also belongs to the p28-Omp multigene 
locus and is referred to as p28-Omp 19. If expression from this gene is important for the 
bacteria growth in both host cell backgrounds or only critical in one or the other, we may 
see selective growth of mutants.  
 
We selected an E. chaffeensis “tuf” promoter to drive the expression of modified group II 
introns targeted to Ech genes (Ech_0126, Ech_1136, and Ech_1143). The tuf promoter 
transcription was previously verified by our research team. This is a strong E. chaffeensis 
promoter which is responsible for the transcription of more than 22 genes, all of which 
are housekeeping genes (GeneBank cp 000236.1).  In this study, we confirmed the 
promoter activity of tuf promoter in E.coli for driving expression of β-galactosidase gene 
activity (Figure 3.5). Subsequently, the promoter was transferred to Targetron constructs. 
The RNA expression from tuf promoter driving the expression of group II modified 
intron and intron encoded protein transcripts were also demonstrated in this study (Figure 
3.11).  These results were important prior to investigating the Targetron constructs in 
creating mutations in E. chaffeensis.  
 
In support of identifying E. chaffeensis mutants, we inserted chloramphenicol 
actyltransferase (CAT) gene coding sequence of E. coli with another constitutively 
expressed E. chaffeensis promoter, rpsl. The rpsl promoter belongs to protein synthesis 
complex genes, ribosomal proteins S12 (Ech_0963). The CAT gene expression from rpsl 
promoter was also confirmed in E. coli by selecting clones resistant to chloramphenicol.  
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The transformant methods for E. chaffeensis required high volumes of purified, viable 
organisms. Our standardized protocols were effective in recovering viable Ehrlichia 
organism. In all three transformation experiments, we were able to demonstrate the 
growth of E. chaffeensis following electroporation. We also standardized conditions for 
transforming E. chaffeensis with Targetron constructs. Several electroporation conditions 
were tested which varied from 1200 V to 2400 V and single and double shocks. We 
found the most effective method of transformation is by providing two electric shocks at 
1800 V.  
 
Several pilot experiments were also performed to purify high quality DNA for use in 
transformation experiments. We found the Qiagen plasmid Endofree maxi kit (Qiagen, 
CA) to be the best in isolating high quality DNA. We also evaluated several plasmid 
DNA concentrations, which ranged from 2 μg to 20 μg and found the higher 
concentration of 20 μg to be the best for transformations. The selection 20 μg was based 
on the published evidence of transformations in other Rickettsial agents, Rickettsia 
prowazekii (Liu et al., 2007). In our final experiment of transformation, we were able 
demonstrate the integration of modified group II introns into E. chaffeensis genome at 
two locations: Ech_0126 and Ech_1143. Insertions at Ech_0126 (gene 126) were 
following for up to 6 days in all three experiments by PCR and Southern blot analysis 
prior to adding chloramphenicol. In the first experiment, the analysis was performed only 
for two days. Predicted (0.89 kb) amplicons were clearly visible following Southern blot 
analysis. Minor bands of expected size were also seen in the agarose gel resolved DNA of 
amplicons obtained for PCR IIa, in which one primer targeted to group II intron and the 
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second primer targeted to the genomic regions 5’ to predicted insertion site. The PCR 
positives in the first experiment, however, decreased with increasing time following 
transformation. The presence of PCR positives, however, was only seen for the first 
harvest, i.e. after 6 h post transformation in the cultured organisms in the second 
experiment. Similar transformation experiments for Ech_1143 (gene 19) also led to 
positive insertions in the genome and are detectable for up to 24 h in culture following 
the transformation. However, we found no evidence of mutations for gene 14 (Ech_1136). 
The detection of PCR positives for mutations in genes 126 and 19 are very encouraging 
and clearly demonstrate that E. chaffeensis genome can be mutated using Targetron-
based insertion mutation methods. Introduction of mutations in E. chaffeensis or other 
species of Ehlichia and Anaplasma genome were not demonstrated earlier. Therefore, 
this study represents an important milestone in advancing the gap of knowledge in 
understanding the significance of host-specific protein expression.  
 
It is not clear why mutated E. chaffeensis for gene 19 and 126 were not stable beyond 24 
h. It is also not clear why the intensity of PCR positive bands decreased with time post 
transformation. One possible explanation for the unstable mutations in culture is that the 
mutants of genes 19 and126 may be slow in their growth compared to wild type E. 
chaffeensis. The absence of positive mutants for gene 14 following Targetron-based 
mutagenesis analysis may be an indication that the loss of this gene function may lead to 
lethal outcome in E. chaffeensis.  
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In our studies, we followed the Targetron mutated E. chaffeensis of genes 19 and 126 for 
up to 2 months by adding the chloramphenicol at a concentration 2 µg/ml to the culture 
media. Our efforts to identify mutants by culture PCR did not result in positive clones. 
This result may be explained due to poor or no expression of chloramphenicol 
actyltransferase protein in E. chaffeensis. This may be important, due to the difference in 
the codons of the CAT gene coding sequences. In particular, the CAT gene construct 
used in our studies was derived from E. coli. The codon usage of E. chaffeensis is 
significantly different from that of E.coli. Future experiments, therefore, should involve 
optimizing the codons of CAT gene to E. chaffeensis. The second possibility is the 
concentration of chloramphenicol. We may consider reducing the chloramphenicol to 
minimum required concentration to inhibit the growth of only the wild type E. chaffeensis, 
but not the mutants. It is also important to investigate the possibility to create Targetron 
based mutations in other regions of E. chaffeensis genome. All these experiment are now 
underway in our laboratory.  
 
In summary, considerable progress has been made in introducing mutation in E. 
chaffeensis. We are the first to demonstrate the feasibility to introducing mutations at two 
regions of E. chaffeensis genome. We standardized numerous protocols needed in support 
of transformation and to create mutations in E. chaffeensis. The Targetron constructs 
developed in this study can be adapted easily to target other genomic regions of E. 
chaffeensis and also for use in creating mutations in other tick borne rickettisal agents of 
the genera Ehrlichia and Anaplasma.  
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Chapte IV 
Major conclusions 
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1. Targetron modified constructs for E. chaffeensis genes Ech_1136, Ech_1143, and 
Ech_0126 were prepared. 
 
2. E. chaffeensis “tuf” promoter was cloned and confirmed its function in E. coli 
using promoterless β-galactosidase expression system.  
 
3. The E. chaffeensis tuf promoter driven expression of group II intron and intron encoded 
protein transcripts were also confirmed in E. coli.  
 
4. The E. chaffeensis rpsl promoter was also cloned and utilized in driving an 
antibiotic selection marker in E. chaffeensis. 
 
5. The final modified Targetron constructs include E. chaffeensis tuf promoter to 
drive the expression of modified group II introns and rpsl promoter to drive the 
expression of chloramphenicol acetyltranferse gene.  
 
6. The Targetron constructs for E. chaffeensis genes 14, 19, and 126 were examined 
for transformation and creating mutations in the pathogen.  
 
7. Mutants for E. chaffeensis genes 19 and 126 were identified in cultures for up to 
48 h in three independent times. 
 
8. No mutants were detected for gene 14. 
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9. The modified Targetron constructs are useful in preparing additional constructs 
for making mutations in alter regions of E. chaffeensis genome as well as for 
studying mutational analysis of other tick-borne pathogens of the genera Ehrlicha 
and Anaplasma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
